<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.1d3 20150301//EN" "http://jats.nlm.nih.gov/publishing/1.1d3/JATS-journalpublishing1.dtd">
<article article-type="research-article" dtd-version="1.1d3" xml:lang="en" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">PLoS Negl Trop Dis</journal-id>
<journal-id journal-id-type="publisher-id">plos</journal-id>
<journal-id journal-id-type="pmc">plosntds</journal-id>
<journal-title-group>
<journal-title>PLOS Neglected Tropical Diseases</journal-title>
</journal-title-group>
<issn pub-type="epub">1935-2735</issn>
<publisher>
<publisher-name>Public Library of Science</publisher-name>
<publisher-loc>San Francisco, CA USA</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.1371/journal.pntd.0004903</article-id>
<article-id pub-id-type="publisher-id">PNTD-D-15-00775</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Research Article</subject>
</subj-group>
<subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Organisms</subject><subj-group><subject>Animals</subject><subj-group><subject>Vertebrates</subject><subj-group><subject>Amniotes</subject><subj-group><subject>Mammals</subject><subj-group><subject>Primates</subject><subj-group><subject>Monkeys</subject><subj-group><subject>Old World monkeys</subject><subj-group><subject>Baboons</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Organisms</subject><subj-group><subject>Protozoans</subject><subj-group><subject>Parasitic protozoans</subject><subj-group><subject>Trypanosoma</subject><subj-group><subject>Trypanosoma brucei gambiense</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Biochemistry</subject><subj-group><subject>Proteins</subject><subj-group><subject>Recombinant proteins</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Biochemistry</subject><subj-group><subject>Proteins</subject><subj-group><subject>Serum proteins</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Physiology</subject><subj-group><subject>Physiological processes</subject><subj-group><subject>Tissue repair</subject><subj-group><subject>Lysis (medicine)</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and health sciences</subject><subj-group><subject>Physiology</subject><subj-group><subject>Physiological processes</subject><subj-group><subject>Tissue repair</subject><subj-group><subject>Lysis (medicine)</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and health sciences</subject><subj-group><subject>Parasitic diseases</subject></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and health sciences</subject><subj-group><subject>Parasitic diseases</subject><subj-group><subject>Protozoan infections</subject><subj-group><subject>Trypanosomiasis</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and health sciences</subject><subj-group><subject>Infectious diseases</subject><subj-group><subject>Zoonoses</subject><subj-group><subject>Trypanosomiasis</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Organisms</subject><subj-group><subject>Animals</subject><subj-group><subject>Vertebrates</subject><subj-group><subject>Amniotes</subject><subj-group><subject>Mammals</subject><subj-group><subject>Primates</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group></article-categories>
<title-group>
<article-title>A Primate APOL1 Variant That Kills <italic>Trypanosoma brucei gambiense</italic></article-title>
<alt-title alt-title-type="running-head">APOL1 Variant That Kills <italic>T</italic>. <italic>b</italic>. <italic>gambiense</italic></alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" xlink:type="simple">
<name name-style="western">
<surname>Cooper</surname>
<given-names>Anneli</given-names>
</name>
<xref ref-type="aff" rid="aff001"><sup>1</sup></xref>
</contrib>
<contrib contrib-type="author" xlink:type="simple">
<name name-style="western">
<surname>Capewell</surname>
<given-names>Paul</given-names>
</name>
<xref ref-type="aff" rid="aff001"><sup>1</sup></xref>
</contrib>
<contrib contrib-type="author" xlink:type="simple">
<name name-style="western">
<surname>Clucas</surname>
<given-names>Caroline</given-names>
</name>
<xref ref-type="aff" rid="aff001"><sup>1</sup></xref>
</contrib>
<contrib contrib-type="author" xlink:type="simple">
<name name-style="western">
<surname>Veitch</surname>
<given-names>Nicola</given-names>
</name>
<xref ref-type="aff" rid="aff001"><sup>1</sup></xref>
</contrib>
<contrib contrib-type="author" xlink:type="simple">
<name name-style="western">
<surname>Weir</surname>
<given-names>William</given-names>
</name>
<xref ref-type="aff" rid="aff001"><sup>1</sup></xref>
</contrib>
<contrib contrib-type="author" xlink:type="simple">
<name name-style="western">
<surname>Thomson</surname>
<given-names>Russell</given-names>
</name>
<xref ref-type="aff" rid="aff002"><sup>2</sup></xref>
</contrib>
<contrib contrib-type="author" xlink:type="simple">
<name name-style="western">
<surname>Raper</surname>
<given-names>Jayne</given-names>
</name>
<xref ref-type="aff" rid="aff002"><sup>2</sup></xref>
</contrib>
<contrib contrib-type="author" corresp="yes" xlink:type="simple">
<name name-style="western">
<surname>MacLeod</surname>
<given-names>Annette</given-names>
</name>
<xref ref-type="aff" rid="aff001"><sup>1</sup></xref>
<xref ref-type="corresp" rid="cor001">*</xref>
</contrib>
</contrib-group>
<aff id="aff001"><label>1</label> <addr-line>Wellcome Trust Centre for Molecular Parasitology, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, United Kingdom</addr-line></aff>
<aff id="aff002"><label>2</label> <addr-line>Department of Medical Parasitology, Langone School of Medicine, New York University, New York, New York, United States of America</addr-line></aff>
<contrib-group>
<contrib contrib-type="editor" xlink:type="simple">
<name name-style="western">
<surname>Büscher</surname>
<given-names>Philippe</given-names>
</name>
<role>Editor</role>
<xref ref-type="aff" rid="edit1"/>
</contrib>
</contrib-group>
<aff id="edit1"><addr-line>Institute of Tropical Medicine, BELGIUM</addr-line></aff>
<author-notes>
<fn fn-type="conflict" id="coi001">
<p>The authors have declared that no competing interests exist.</p>
</fn>
<fn fn-type="con" id="contrib001">
<p>Conceived and designed the experiments: AM AC PC CC NV. Performed the experiments: AC PC CC NV. Analyzed the data: AC PC CC. Contributed reagents/materials/analysis tools: WW JR RT. Wrote the paper: AC PC AM CC WW JR RT.</p>
</fn>
<corresp id="cor001">* E-mail: <email xlink:type="simple">annette.macleod@glasgow.ac.uk</email></corresp>
</author-notes>
<pub-date pub-type="epub">
<day>5</day>
<month>8</month>
<year>2016</year>
</pub-date>
<pub-date pub-type="collection">
<month>8</month>
<year>2016</year>
</pub-date>
<volume>10</volume>
<issue>8</issue>
<elocation-id>e0004903</elocation-id>
<history>
<date date-type="received">
<day>8</day>
<month>5</month>
<year>2015</year>
</date>
<date date-type="accepted">
<day>14</day>
<month>7</month>
<year>2016</year>
</date>
</history>
<permissions>
<copyright-year>2016</copyright-year>
<copyright-holder>Cooper et al</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/" xlink:type="simple">
<license-p>This is an open access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/" xlink:type="simple">Creative Commons Attribution License</ext-link>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</license-p>
</license>
</permissions>
<self-uri content-type="pdf" xlink:href="info:doi/10.1371/journal.pntd.0004903"/>
<abstract>
<p>Humans are protected against infection from most African trypanosomes by lipoprotein complexes present in serum that contain the trypanolytic pore-forming protein, Apolipoprotein L1 (APOL1). The human-infective trypanosomes, <italic>Trypanosoma brucei rhodesiense</italic> in East Africa and <italic>T</italic>. <italic>b</italic>. <italic>gambiense</italic> in West Africa have separately evolved mechanisms that allow them to resist APOL1-mediated lysis and cause human African trypanosomiasis, or sleeping sickness, in man. Recently, APOL1 variants were identified from a subset of Old World monkeys, that are able to lyse East African <italic>T</italic>. <italic>b</italic>. <italic>rhodesiense</italic>, by virtue of C-terminal polymorphisms in the APOL1 protein that hinder that parasite’s resistance mechanism. Such variants have been proposed as candidates for developing therapeutic alternatives to the unsatisfactory anti-trypanosomal drugs currently in use. Here we demonstrate the <italic>in vitro</italic> lytic ability of serum and purified recombinant protein of an APOL1 ortholog from the West African Guinea baboon (<italic>Papio papio)</italic>, which is able to lyse examples of all sub-species of <italic>T</italic>. <italic>brucei</italic> including <italic>T</italic>. <italic>b</italic>. <italic>gambiense</italic> group 1 parasites, the most common agent of human African trypanosomiasis. The identification of a variant of APOL1 with trypanolytic ability for both human-infective <italic>T</italic>. <italic>brucei</italic> sub-species could be a candidate for universal APOL1-based therapeutic strategies, targeted against all pathogenic African trypanosomes.</p>
</abstract>
<abstract abstract-type="summary">
<title>Author Summary</title>
<p>African trypanosomes are protozoan parasites that affect both humans and animals in poor rural areas of sub-Saharan Africa, and are a major constraint on health and agricultural development. Disease control is principally dependent on the administration of drugs, which are old and largely unsatisfactory. Humans are naturally resistant to infection by most African trypanosomes species because of a lytic protein component in their blood, called APOL1. However, human-infective trypanosomes, <italic>T</italic>. <italic>b</italic>. <italic>rhodesiense</italic> in East Africa, and <italic>T</italic>. <italic>b</italic>. <italic>gambiense</italic> in West Africa, have evolved separate mechanisms to disarm this lytic protein and cause disease. Recently, variants of APOL1 were discovered in some primates that are able to kill the East African human disease-causing sub-species. These APOL1 variants form the basis of current attempts to create novel therapeutic interventions that can kill both animal and human-infective trypanosomes. In this study, we show that another variant of the same protein from a West African baboon species is able to kill, not only East African human-infective trypanosomes, but also the West African parasites, which causes the majority of human African trypanosomiasis cases. This new APOL1 variant could be a potential candidate for anti-trypanosomal therapies targeted at all pathogenic trypanosome species.</p>
</abstract>
<funding-group>
<award-group id="award001">
<funding-source>
<institution>The Wellcome Trust</institution>
</funding-source>
<award-id>095201/Z/10/Z</award-id>
<principal-award-recipient>
<name name-style="western">
<surname>MacLeod</surname>
<given-names>Annette</given-names>
</name>
</principal-award-recipient>
</award-group>
<funding-statement>AC PC CC NV WW are supported by a Wellcome Senior Fellowship Grant awarded to AM [095201/Z/10/Z]. The Wellcome Trust Centre for Molecular Parasitology is supported by core funding from the Wellcome Trust [085349]. The funders had no role in study design, data collection and analysis or the decision to publish.</funding-statement>
</funding-group>
<counts>
<fig-count count="4"/>
<table-count count="0"/>
<page-count count="20"/>
</counts>
<custom-meta-group>
<custom-meta id="data-availability">
<meta-name>Data Availability</meta-name>
<meta-value>All relevant data are within the paper and its Supporting Information files.</meta-value>
</custom-meta>
</custom-meta-group>
</article-meta>
</front>
<body>
<sec id="sec001" sec-type="intro">
<title>Introduction</title>
<p>African trypanosomes continue to exert a significant barrier to agricultural production and rural development across sub-Saharan Africa [<xref ref-type="bibr" rid="pntd.0004903.ref001">1</xref>]. Due to a primate-specific innate trypanolytic mechanism, the majority of trypanosome species are unable to infect man. However, two sub-species of <italic>Trypanosoma brucei</italic>, <italic>T</italic>. <italic>b</italic>. <italic>rhodesiense</italic> and <italic>T</italic>. <italic>b</italic>. <italic>gambiense</italic>, have evolved distinct processes to resist this lysis and cause the debilitating and often fatal human form of African trypanosomiasis, known as sleeping sickness. The West African <italic>T</italic>. <italic>b</italic>. <italic>gambiense</italic> parasite typically causes a chronic disease profile, while the zoonotic <italic>T</italic>. <italic>b</italic>. <italic>rhodesiense</italic> sub-species, located in Eastern and Southern Africa, results in a more rapidly progressing, acute infection [<xref ref-type="bibr" rid="pntd.0004903.ref002">2</xref>,<xref ref-type="bibr" rid="pntd.0004903.ref003">3</xref>]. Seventy-million people over an area of 1.55 million km<sup>2</sup> are at risk of contracting either of the two human-infective sub-species [<xref ref-type="bibr" rid="pntd.0004903.ref004">4</xref>].</p>
<p>Current anti-trypanosomal drugs for medical and veterinary administration are largely unsatisfactory due to high toxicity, difficult treatment regimens, and emerging resistance [<xref ref-type="bibr" rid="pntd.0004903.ref005">5</xref>–<xref ref-type="bibr" rid="pntd.0004903.ref007">7</xref>]. Decades of drug development for African trypanosomiasis has produced safer refinements of existing therapies [<xref ref-type="bibr" rid="pntd.0004903.ref007">7</xref>,<xref ref-type="bibr" rid="pntd.0004903.ref008">8</xref>] and a number of promising novel drug candidates [<xref ref-type="bibr" rid="pntd.0004903.ref009">9</xref>–<xref ref-type="bibr" rid="pntd.0004903.ref011">11</xref>], but as yet no new anti-trypanosomal therapy has successfully passed phase III clinical trials. Furthermore, the adaptive immune response of vertebrates is rendered largely ineffective by the trypanosome’s ability to cyclically evade detection through variant surface glycoprotein (VSG)-mediated antigenic variation [<xref ref-type="bibr" rid="pntd.0004903.ref012">12</xref>,<xref ref-type="bibr" rid="pntd.0004903.ref013">13</xref>], placing a significant hurdle in the path of vaccine development. Broad-spectrum, safe, easily administered, and effective therapies to treat African trypanosomiasis are therefore still needed. The recent discovery of primate serum proteins that are able to kill both animal and human-infective trypanosomes is now offering opportunities for novel therapeutic approaches [<xref ref-type="bibr" rid="pntd.0004903.ref014">14</xref>,<xref ref-type="bibr" rid="pntd.0004903.ref015">15</xref>].</p>
<p>It has been known for over a century that the serum of humans and a small number of other Catarrhine primates are highly toxic to most African trypanosome species [<xref ref-type="bibr" rid="pntd.0004903.ref016">16</xref>,<xref ref-type="bibr" rid="pntd.0004903.ref017">17</xref>]. The molecular basis of this innate immunity in man has been elucidated and centres on two trypanolytic serum complexes, Trypanosome Lytic Factor 1 (TLF-1) [<xref ref-type="bibr" rid="pntd.0004903.ref018">18</xref>,<xref ref-type="bibr" rid="pntd.0004903.ref019">19</xref>] and TLF-2 [<xref ref-type="bibr" rid="pntd.0004903.ref020">20</xref>,<xref ref-type="bibr" rid="pntd.0004903.ref021">21</xref>], which share the same core protein components: haptoglobin-related protein (HPR) and apolipoprotein L1 (APOL1). HPR bound to haemoglobin mediates TLF-1 endocytosis via the haem-scavenging, haptoglobin-haemoglobin receptor (HpHbR) on the trypanosome’s surface [<xref ref-type="bibr" rid="pntd.0004903.ref022">22</xref>–<xref ref-type="bibr" rid="pntd.0004903.ref025">25</xref>]. Difficulty in purifying TLF-2 <italic>ex-vivo</italic>, has hindered discovery of exactly how this complex is bound and internalised by the parasite but it is known that it does not require HpHbR [<xref ref-type="bibr" rid="pntd.0004903.ref021">21</xref>,<xref ref-type="bibr" rid="pntd.0004903.ref026">26</xref>]. Despite differences in uptake, both TLF-1 and TLF-2 utilize the same lytic component in the form of the ionic channel-forming protein, APOL1 [<xref ref-type="bibr" rid="pntd.0004903.ref022">22</xref>,<xref ref-type="bibr" rid="pntd.0004903.ref027">27</xref>,<xref ref-type="bibr" rid="pntd.0004903.ref028">28</xref>]. Following internalization, APOL1 undergoes a pH-dependant conformational change in the endolysosome pathway which releases it from the TLF complex [<xref ref-type="bibr" rid="pntd.0004903.ref029">29</xref>,<xref ref-type="bibr" rid="pntd.0004903.ref030">30</xref>], and promotes insertion into parasite membranes [<xref ref-type="bibr" rid="pntd.0004903.ref031">31</xref>,<xref ref-type="bibr" rid="pntd.0004903.ref032">32</xref>]. The exact mechanism of APOL1-mediated lysis that follows remains to be elucidated. In one recent model APOL1 insertion was found to disrupt both lysosomal and mitochondrial membranes, inducing an apoptosis-like cell death [<xref ref-type="bibr" rid="pntd.0004903.ref033">33</xref>]. In contrast, an alternative model proposes that endosome recycling of APOL1 to the neutral environment of the parasite’s plasma membrane accelerates cation-selective channel activity and promotes lysis by osmotic swelling [<xref ref-type="bibr" rid="pntd.0004903.ref034">34</xref>].</p>
<p>The <italic>Trypanosoma</italic> parasites responsible for animal trypanosomiasis are rapidly killed by this innate defence system, whereas the human sleeping sickness parasites, <italic>T</italic>. <italic>b</italic>. <italic>rhodesiense</italic> and <italic>T</italic>. <italic>b</italic>. <italic>gambiense</italic>, are able to resist lysis. In <italic>T</italic>. <italic>b</italic>. <italic>rhodesiense</italic>, resistance is effected by the VSG-derived, serum resistance associated (SRA) protein [<xref ref-type="bibr" rid="pntd.0004903.ref035">35</xref>,<xref ref-type="bibr" rid="pntd.0004903.ref036">36</xref>] which binds to the C-terminal domain of APOL1 in the endolysosome pathway preventing channel-mediated lysis [<xref ref-type="bibr" rid="pntd.0004903.ref027">27</xref>,<xref ref-type="bibr" rid="pntd.0004903.ref037">37</xref>–<xref ref-type="bibr" rid="pntd.0004903.ref039">39</xref>], plausibly by impeding correct membrane insertion of APOL1 [<xref ref-type="bibr" rid="pntd.0004903.ref034">34</xref>,<xref ref-type="bibr" rid="pntd.0004903.ref040">40</xref>].</p>
<p>The mechanism of human serum resistance in <italic>T</italic>. <italic>b</italic>. <italic>gambiense</italic> has taken longer to unravel. <italic>T</italic>. <italic>b</italic>. <italic>gambiense</italic> typically grows to very low parasitemia and is difficult to adapt to laboratory models. An additional complicating factor is that <italic>T</italic>. <italic>b</italic>. <italic>gambiense</italic> shows two distinct "groups" that differ in genotype and phenotype [<xref ref-type="bibr" rid="pntd.0004903.ref041">41</xref>–<xref ref-type="bibr" rid="pntd.0004903.ref044">44</xref>]. The classic, clonal <italic>T</italic>. <italic>b</italic>. <italic>gambiense</italic> type [<xref ref-type="bibr" rid="pntd.0004903.ref045">45</xref>], labelled “group 1” and found in West and Central Africa, is the predominant human-infective sub-species, responsible for 97% of all reported human cases [<xref ref-type="bibr" rid="pntd.0004903.ref046">46</xref>]. <italic>T</italic>. <italic>b</italic>. <italic>gambiense</italic> group 1 strains are invariably resistant even after prolonged passage in laboratory rodents [<xref ref-type="bibr" rid="pntd.0004903.ref042">42</xref>,<xref ref-type="bibr" rid="pntd.0004903.ref047">47</xref>] and the mechanism underlying this resistance appears multifactorial, with at least three independent contributing components so far identified. Firstly the reduction of TLF-1 uptake through reduced expression and polymorphism of the <italic>HpHbR</italic> receptor that reduces binding affinity [<xref ref-type="bibr" rid="pntd.0004903.ref048">48</xref>–<xref ref-type="bibr" rid="pntd.0004903.ref050">50</xref>]; secondly, expression of a VSG-related <italic>T</italic>. <italic>b</italic>. <italic>gambiense</italic>-specific glycoprotein (TgsGP) which is essential, but not sufficient, for resistance [<xref ref-type="bibr" rid="pntd.0004903.ref051">51</xref>] and which may increase resistance to APOL1 pore-mediated lysis by stiffening trypanosomal membranes [<xref ref-type="bibr" rid="pntd.0004903.ref052">52</xref>]; and thirdly, faster APOL1 degradation has been proposed, through the action of cysteine peptidase [<xref ref-type="bibr" rid="pntd.0004903.ref052">52</xref>,<xref ref-type="bibr" rid="pntd.0004903.ref053">53</xref>]. A second, more virulent type of <italic>T</italic>. <italic>b</italic>. <italic>gambiense</italic> was identified in Cote d’Ivoire and Burkina Faso in the 1980’s [<xref ref-type="bibr" rid="pntd.0004903.ref042">42</xref>,<xref ref-type="bibr" rid="pntd.0004903.ref044">44</xref>] and defined as “group 2”, but has since virtually disappeared and may now be extinct. Studies of the limited number of group 2 strains that have been isolated indicate that these parasites are closely related to West Africa <italic>T</italic>. <italic>b</italic>. <italic>brucei</italic> [<xref ref-type="bibr" rid="pntd.0004903.ref041">41</xref>,<xref ref-type="bibr" rid="pntd.0004903.ref043">43</xref>,<xref ref-type="bibr" rid="pntd.0004903.ref044">44</xref>,<xref ref-type="bibr" rid="pntd.0004903.ref054">54</xref>] and exhibit a variable human serum resistance phenotype, in a manner superficially similar to <italic>T</italic>. <italic>b</italic>. <italic>rhodesiense</italic> [<xref ref-type="bibr" rid="pntd.0004903.ref042">42</xref>,<xref ref-type="bibr" rid="pntd.0004903.ref047">47</xref>,<xref ref-type="bibr" rid="pntd.0004903.ref048">48</xref>]. Although the underlying resistance mechanism remains elusive it does not appear to involve a reduction in TLF-1 uptake [<xref ref-type="bibr" rid="pntd.0004903.ref048">48</xref>] or the <italic>SRA</italic> [<xref ref-type="bibr" rid="pntd.0004903.ref055">55</xref>] or <italic>TgsGP</italic> gene [<xref ref-type="bibr" rid="pntd.0004903.ref056">56</xref>,<xref ref-type="bibr" rid="pntd.0004903.ref057">57</xref>].</p>
<p>Unlike humans and gorillas [<xref ref-type="bibr" rid="pntd.0004903.ref058">58</xref>,<xref ref-type="bibr" rid="pntd.0004903.ref059">59</xref>], from which they diverged around 25 million years ago [<xref ref-type="bibr" rid="pntd.0004903.ref060">60</xref>], several members of the Cercopithecidae (Old World monkey) family appear intrinsically resistant to <italic>T</italic>. <italic>b</italic>. <italic>rhodesiense</italic> [<xref ref-type="bibr" rid="pntd.0004903.ref058">58</xref>,<xref ref-type="bibr" rid="pntd.0004903.ref059">59</xref>,<xref ref-type="bibr" rid="pntd.0004903.ref061">61</xref>]. Both serum and APOL1 from the East African baboon species, <italic>Papio hamadryas</italic>, has been demonstrated to effectively lyse human-infective <italic>T</italic>. <italic>b</italic>. <italic>rhodesiense</italic> [<xref ref-type="bibr" rid="pntd.0004903.ref014">14</xref>,<xref ref-type="bibr" rid="pntd.0004903.ref058">58</xref>]. This difference in innate immunity between <italic>Homo sapiens</italic> and <italic>P</italic>. <italic>hamadryas</italic>, has been pinpointed to the position of a single amino acid in the baboon APOL1 C-terminus which prevents the parasite’s SRA protein from binding and neutralising APOL1 lytic activity [<xref ref-type="bibr" rid="pntd.0004903.ref062">62</xref>]. Furthermore, a nearly identical mutation has now also been detected in the C-terminus of APOL1 variants of some humans with African ancestry whose serum exhibits lytic activity against <italic>T</italic>. <italic>b</italic>. <italic>rhodesiense</italic> but not <italic>T</italic>. <italic>b</italic>. <italic>gambiense</italic> [<xref ref-type="bibr" rid="pntd.0004903.ref063">63</xref>].</p>
<p>This led to the hypothesis that as <italic>T</italic>. <italic>b</italic>. <italic>gambiense</italic> is found only in West Africa, another variant of APOL1 may exist in some West African primates that is able to kill <italic>T</italic>. <italic>b</italic>. <italic>gambiense</italic>. In this study we examined the serum and APOL1 protein of a West African baboon species, <italic>Papio papio</italic>, suggested to be refractory to <italic>T</italic>. <italic>b</italic>. <italic>gambiense</italic> infection, with the ability to eliminate parasites in a laboratory infection [<xref ref-type="bibr" rid="pntd.0004903.ref064">64</xref>]. Here we demonstrate that serum and recombinant protein from the <italic>P</italic>. <italic>papio</italic> APOL1 ortholog lyses representative strains of all sub-species of <italic>T</italic>. <italic>brucei</italic> in an <italic>in vitro</italic> assay system. The identification of an APOL1 variant with broad trypanolytic ability against <italic>T</italic>. <italic>brucei</italic> sub-species, including the most prevalent <italic>T</italic>. <italic>b</italic>. <italic>gambiense</italic> type, may provide a potential reagent for the development of universal APOL1-based therapeutic agents.</p>
</sec>
<sec id="sec002" sec-type="materials|methods">
<title>Methods</title>
<sec id="sec003">
<title><italic>Trypanosoma brucei</italic> stocks</title>
<p>Representative bloodstream form cell lines were selected for each subspecies from a collection at the University of Glasgow and have been previously described. STIB247 is a <italic>T</italic>. <italic>b</italic>. <italic>brucei</italic> strain originally isolated from a hartebeest in Serengeti, Tanzania in 1971 [<xref ref-type="bibr" rid="pntd.0004903.ref065">65</xref>]. The <italic>T</italic>. <italic>b</italic>. <italic>rhodesiense</italic> strain EATRO98 was isolated by the East African Trypanosomiasis Research Organization (EATRO) from a human in Nyanza, Kenya in 1961 [<xref ref-type="bibr" rid="pntd.0004903.ref066">66</xref>]. <italic>T</italic>. <italic>b</italic>. <italic>gambiense</italic> group 2 strain STIB386 (MHOM/CI/78/TH114) was originally isolated in 1978 from an infected patient in Côte d'Ivoire [<xref ref-type="bibr" rid="pntd.0004903.ref067">67</xref>]. ELIANE (MHOM/CI/52/ITMAP 2188) is a <italic>T</italic>. <italic>b</italic>. <italic>gambiense</italic> group 1 strain isolated from a human in Côte d’Ivoire in 1952 [<xref ref-type="bibr" rid="pntd.0004903.ref068">68</xref>]. Additional <italic>T</italic>. <italic>b</italic>. <italic>gambiense</italic> group 1 strains tested were human isolates, PA (MHOM/CG/80/ITMAP1843/PA) from Republic of the Congo in 1975 [<xref ref-type="bibr" rid="pntd.0004903.ref043">43</xref>], BIM (MHOM/CM/75/ITMAP1789/BIM) from Cameroon in 1975 [<xref ref-type="bibr" rid="pntd.0004903.ref043">43</xref>], and TOBO (MHOM/CI/83/DAL596/TOBO) and S1/1/6 RI from Côte d'Ivoire in 1983 [<xref ref-type="bibr" rid="pntd.0004903.ref069">69</xref>] and 2002 [<xref ref-type="bibr" rid="pntd.0004903.ref070">70</xref>], respectively. All bloodstream form culture lines were maintained <italic>in vitro</italic> in modified HMI9 medium [<xref ref-type="bibr" rid="pntd.0004903.ref071">71</xref>] supplemented by 1.5 mM glucose, 1 mM methyl cellulose, 250 μM adenosine, 150 μM guanosine and 20% foetal bovine serum (FBS). Expression of the <italic>SRA</italic> human serum resistance gene in <italic>T</italic>. <italic>b</italic>. <italic>rhodesiense</italic> EATRO98 was maintained under selection with 1% normal human serum. Ectopic expression of functional <italic>T</italic>. <italic>b</italic>. <italic>brucei HpHbR</italic> in ELIANE was previously generated using the tubulin-targeting <italic>TbbHpHbR</italic> pTub-phelo construct (strain ELIANE <italic>TbbHpHbR</italic><sup><italic>-/+</italic></sup>) [<xref ref-type="bibr" rid="pntd.0004903.ref051">51</xref>], and maintained under phleomycin selection. Bloodstream form isolates BIM and S1/1/6 RI were grown from stabilate in donor BALB/C mice (Harlan, United Kingdom) and trypanosomes purified from blood by differential centrifugation as previously described [<xref ref-type="bibr" rid="pntd.0004903.ref072">72</xref>]. Cells were maintained as for bloodstream culture cells lines at 37°C in 5% CO<sub>2</sub> for up to 24 hours until use. All animal procedures were carried out in accordance with the Animals (Scientific Procedures) Act of 1986. Subspecies classification for <italic>T</italic>. <italic>b</italic>. <italic>gambiense</italic> group 1 strains was confirmed by a positive PCR result for the <italic>T</italic>. <italic>b</italic>. <italic>gambiense</italic> specific glycoprotein (<italic>TgsGP</italic>) gene and <italic>T</italic>. <italic>b</italic>. <italic>rhodesiense</italic> by a positive PCR result for the subspecies-specific serum resistance-associated (<italic>SRA</italic>) gene, as previously described [<xref ref-type="bibr" rid="pntd.0004903.ref048">48</xref>]. <italic>T</italic>. <italic>b</italic>. <italic>brucei</italic> and <italic>T</italic>. <italic>b</italic>. <italic>gambiense</italic> group 2 strains were confirmed by a combination of negative <italic>SRA</italic>/<italic>TgsGP</italic> PCR results, the human serum sensitivity phenotype and their microsatellite genetic profile [<xref ref-type="bibr" rid="pntd.0004903.ref073">73</xref>].</p>
</sec>
<sec id="sec004">
<title>Serum stocks</title>
<p>Sera Laboratories International, UK, provided pooled adult <italic>P</italic>. <italic>papio</italic> baboon serum derived from two individuals. Additional <italic>P</italic>. <italic>papio</italic> baboon serum, derived from a single adult male individual, was provided by Matrix Biologicals, UK. Normal human serum was obtained from a consented human donor and subject to appropriate ethical approval. The APOL1 protein levels in all serum samples are unquantified.</p>
</sec>
<sec id="sec005">
<title>Serum resistance assays</title>
<p>Trypanosomes were diluted to 5 x 10<sup>5</sup> parasites per ml in modified HMI9, with the addition of human serum or <italic>P</italic>. <italic>papio</italic> serum serially diluted in foetal bovine serum (FBS), or FBS only, to a total concentration of 20%. Assays were performed in a final volume of 200 μl in a standard 96 well plate at 37°C in a CO<sub>2</sub>-equilibrated incubator. The number of viable motile trypanosomes was quantified at 24 hours by haemocytometer counts under the microscope in triplicate, for at least three independent experiments. The percentage viability of parasites in human or <italic>P</italic>. <italic>papio</italic> serum was normalised relative to the FBS control for each cell line to account for inherent differences in strain growth rate. Dose–response curves and IC<sub>50</sub> values were determined using GraphPad Prism software (version 7.0).</p>
</sec>
<sec id="sec006">
<title>Cloning and expression of recombinant APOL1</title>
<p>The <italic>H</italic>. <italic>sapiens</italic> (accession no. CCDS13926.1) or <italic>P</italic>. <italic>papio</italic> (accession no. KC197810) APOL1 open reading frame (ORF) was synthesised and supplied by GeneArt life technologies in an Invitrogen Gateway-compatible entry vector. The entry vector containing the <italic>APOL1</italic> cDNA sequence, minus the N-terminal signal peptide (<italic>H</italic>. <italic>sapiens</italic>, residues 28–398; <italic>P</italic>. <italic>papio</italic>, residues 28–288) was cloned into pDest17 destination vector, which added an N-terminal 6xHis-tag, and transformed into BL21- AI competent <italic>E</italic>. <italic>coli</italic>. Protein expression was induced using 0.2% L-Arabinose for 16 hours at 37°C. Cells were lysed with urea lysis buffer (8 M urea, 20 mM Tris-HCl, 0.5 M NaCl, 5 mM imidazole, pH 8) and the cellular detritus removed by centrifugation at 5000g for 15 minutes. A small aliquot was removed for analysis by SDS-PAGE and Western blot with 1:5000 HRP-conjugated mouse anti-His antibody (Qiagen) and the remainder was used for protein purification under denaturing conditions. Denatured 6x His-tagged APOL1 protein was purified by passing the cell lysate through a gravity-flow Ni-Sepharose column (Gravitrap, GE Healthcare), and washing several times with urea lysis buffer pH 8 supplemented with increasing concentrations of Imidazole (5 mM-50 mM). Finally, bound protein was eluted with urea lysis buffer pH 8 containing 500mM imidazole. The eluate was dialyzed overnight against 20mM acetic acid and 0.05% tween and concentrated using 10,000 MW Vivaspin columns (Sartorius). Purity and concentration of the final purified protein was checked using a Qubit fluorometer (Thermo fisher) and SDS-PAGE (<xref ref-type="supplementary-material" rid="pntd.0004903.s001">S1 Fig</xref>), then the concentration adjusted to 1 mg/ml and stored in aliquots at 4°C.</p>
</sec>
<sec id="sec007">
<title>Recombinant APOL1 lysis assay</title>
<p>To assess survival in recombinant APOL1, trypanosomes were diluted to 5 x 10<sup>5</sup> parasites per ml in modified HMI9 containing 20% FBS and incubated with a dilution series of recombinant human or <italic>P</italic>. <italic>papio</italic> APOL1. The recombinant APOL1 was formulated in protein-free buffer (20mM acetic acid, 0.05% tween) and added in a volume of 10 μl to a final assay volume of 200 μl in a standard 96 well plate. A control containing an equivalent volume of protein-free buffer was also prepared. Assays were performed at 37°C in a CO<sub>2</sub>-equilibrated incubator, and the number of viable motile trypanosomes in each well was quantified at 24 hours by haemocytometer counts under the microscope in triplicate for at least three independent experiments. Cell counts in recombinant APOL1 were compared to control wells containing protein-free buffer only to determine percentage survival. In each assay, cells were incubated in 20% normal human serum as a positive control. Dose–response curves, IC<sub>50</sub> values and one-way ANOVA were determined using GraphPad Prism software (version 7.0). Where indicated, trypanosomes were pre-incubated with 10 mM ammonium chloride (NH<sub>4</sub>Cl), a weak base, for 30 minutes at 37°C to reverse acidification of the endolysosome system prior to the addition of recombinant APOL1.</p>
</sec>
<sec id="sec008">
<title>APOL1 localisation immunofluorescence assays</title>
<p>Samples for IFA were prepared as follows. All incubation steps unless stated otherwise were performed in a humidor at room temperature. Bloodstream form trypanosomes were diluted in HMI9 medium containing 20% FBS at a concentration of 10<sup>6</sup> parasites/ml and incubated with 50 μg/ml purified recombinant <italic>H</italic>. <italic>sapiens</italic> or <italic>P</italic>. <italic>papio</italic> APOL1 for two hours at 37°C. After this period, cells were washed once in serum-free HMI9 medium, and settled onto glass slides before fixing in 1% paraformaldehyde for 10 minutes. Samples were permeabilised using 0.1% Triton X-100 in PBS for 20 minutes then incubated in blocking solution (2% BSA in PBS) for 20 minutes. After washing three times in PBS, slides were incubated for 40 minutes with 1:500 mouse anti-p67 antibody (gift from Jay Bangs, Department of Microbiology and Immunology, University at Buffalo, NY, USA) in blocking solution. Washes were repeated and then primary antibody was detected using 1:1000 goat anti-mouse AlexaFluor594 secondary antibody (Life technologies) incubated for 40 minutes in blocking solution. To detect His-tagged APOL1 slides were washed three times in PBS and then incubated for 40 minutes with 1:500 AlexaFluor488 mouse anti-penta-His antibody (Molecular Probes, Invitrogen) in blocking solution. Following a final three washes the cells were treated with 50% glycerol, 0.1% DAPI, 2.5% 1, 4-diazabicyclo [2.2.2] octane (DABCO) in PBS, protected with a coverslip and sealed with acetone. Slides were imaged using the Deltavision Core system and SoftWorx package (Applied Precision) with standard filter sets (DAPI/FITC/Texas-Red and Light transmission). Approximately 30 serial sections through each trypanosome were taken for each filter. The images were composited and the brightness, contrast and color levels normalised between samples and exposures using the ImageJ software package (US National Institute of Health).</p>
</sec>
<sec id="sec009">
<title>Ethics statement</title>
<p>The University of Glasgow ethical review board approved the use of human serum in this study. The human serum volunteer gave written informed consent.</p>
</sec>
</sec>
<sec id="sec010" sec-type="results">
<title>Results</title>
<sec id="sec011">
<title><italic>P</italic>. <italic>papio</italic> serum is lethal to <italic>T</italic>. <italic>b</italic>. <italic>rhodesiense</italic> and <italic>T</italic>. <italic>b</italic>. <italic>gambiense</italic> groups 1 and 2</title>
<p>Trypanolytic activity against the human-infective East African <italic>T</italic>. <italic>b</italic>. <italic>rhodesiense</italic> sub-species has been demonstrated for sera from several members of the Cercopithecidae family, including baboons, mandrills and sooty mangabeys [<xref ref-type="bibr" rid="pntd.0004903.ref014">14</xref>,<xref ref-type="bibr" rid="pntd.0004903.ref037">37</xref>,<xref ref-type="bibr" rid="pntd.0004903.ref058">58</xref>,<xref ref-type="bibr" rid="pntd.0004903.ref059">59</xref>]. To date however, no primate has been identified with lytic activity against West African <italic>T</italic>. <italic>b</italic>. <italic>gambiense</italic> parasites. To determine the trypanolytic ability of serum from the West African Guinea baboon, <italic>P</italic>. <italic>papio</italic>, representative examples of the different <italic>T</italic>. <italic>brucei</italic> sub-species, were incubated for 24 hours <italic>in vitro</italic>, with a dilution series of <italic>P</italic>. <italic>papio</italic> or human serum. The strains selected included five different isolates of classic <italic>T</italic>. <italic>b</italic>. <italic>gambiense</italic> group 1, the cause of 97% of reported HAT cases [<xref ref-type="bibr" rid="pntd.0004903.ref046">46</xref>], from a number of different disease foci in West Africa. As illustrated in <xref ref-type="fig" rid="pntd.0004903.g001">Fig 1A</xref>, normal human serum efficiently lysed <italic>T</italic>. <italic>b</italic>. <italic>brucei</italic> bloodstream parasites (IC<sub>50</sub>; 0.0005%) in a 24 hour assay, but not strains of the human-infective <italic>T</italic>. <italic>b</italic>. <italic>rhodesiense</italic> or <italic>T</italic>. <italic>b</italic>. <italic>gambiense</italic> subspecies. In contrast, <italic>P</italic>. <italic>papio</italic> (pooled sera) was completely lytic to all tested strains, including both <italic>T</italic>. <italic>b</italic>. <italic>gambiense</italic> group 1 and 2 isolates, at concentrations ≥ 10% (<xref ref-type="fig" rid="pntd.0004903.g001">Fig 1B</xref>). The sensitivity of <italic>T</italic>. <italic>b</italic>. <italic>brucei</italic> to <italic>P</italic>. <italic>papio</italic> pooled serum (IC<sub>50</sub>; 0.00035%) was comparable to that of <italic>T</italic>. <italic>b</italic>. <italic>rhodesiense</italic> (IC<sub>50</sub>; 0.00038%). <italic>T</italic>. <italic>b</italic>. <italic>gambiense</italic> group 1 and 2 strains however, were killed significantly less potently, with an IC<sub>50</sub> approximately 70-fold (IC<sub>50</sub>; 0.024% serum, <italic>T</italic>. <italic>b</italic>. <italic>gambiense</italic> group 2) or 2000-fold (IC<sub>50</sub>; 0.46–1.68% serum, <italic>T</italic>. <italic>b</italic>. <italic>gambiense</italic> group 1) higher than that of the other sub-species, although still at a sub-physiological concentration. The trypanolytic activity of <italic>P</italic>. <italic>papio</italic> was also confirmed against a smaller collection of <italic>T</italic>. <italic>brucei</italic> strains using an alternative source of <italic>P</italic>. <italic>papio</italic> sera derived from a single male individual, which killed <italic>T</italic>. <italic>b</italic>. <italic>gambiense</italic> at a lower concentration &gt; 2% (<xref ref-type="supplementary-material" rid="pntd.0004903.s002">S2 Fig</xref>), presumably reflecting variation between individual animal samples.</p>
<fig id="pntd.0004903.g001" position="float">
<object-id pub-id-type="doi">10.1371/journal.pntd.0004903.g001</object-id>
<label>Fig 1</label>
<caption>
<title>Titration of the trypanolytic activity of Human (<italic>H</italic>. <italic>sapiens</italic>) and Guinea baboon (<italic>P</italic>. <italic>papio)</italic> sera against representative examples of the <italic>T</italic>. <italic>brucei</italic> sub-species.</title>
<p>The percentage of viable trypanosomes was determined following a 24-hour exposure to serial dilutions of (A) Human (<italic>H</italic>. <italic>sapiens</italic>) or (B) Guinea baboon (<italic>P</italic>. <italic>papio)</italic> sera. Representative <italic>T</italic>. <italic>brucei</italic> sub-species strains were tested: <italic>T</italic>. <italic>b</italic>. <italic>brucei</italic> (strain STIB247), <italic>T</italic>. <italic>b</italic>. <italic>rhodesiense</italic> (strain EATRO98), <italic>T</italic>. <italic>b</italic>. <italic>gambiense</italic> group 2 (strain STIB386), and <italic>T</italic>. <italic>b</italic>. <italic>gambiense</italic> group 1 (strains ELIANE, TOBO and S1/1/6 [Côte d'Ivoire], PA [Republic of the Congo], and BIM [Cameroon]). Mean percentage cell survival ± SD is expressed relative to FBS control, calculated from three independent experiments. Dose–response curves and IC<sub>50</sub> values with 95% confidence intervals (CI) were determined using GraphPad Prism software version 7.</p>
</caption>
<graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pntd.0004903.g001" xlink:type="simple"/>
</fig>
</sec>
<sec id="sec012">
<title>Lytic activity of <italic>P</italic>. <italic>papio</italic> recombinant APOL1</title>
<p>APOL1 has been demonstrated to be the lytic factor in normal human serum [<xref ref-type="bibr" rid="pntd.0004903.ref022">22</xref>,<xref ref-type="bibr" rid="pntd.0004903.ref027">27</xref>,<xref ref-type="bibr" rid="pntd.0004903.ref028">28</xref>], and <italic>T</italic>. <italic>b</italic>. <italic>rhodesiense-</italic>lytic orthologs of APOL1 have now been identified in the serum of a number of Old World monkey species, including species of the <italic>Papio</italic> baboon genus [<xref ref-type="bibr" rid="pntd.0004903.ref014">14</xref>,<xref ref-type="bibr" rid="pntd.0004903.ref037">37</xref>,<xref ref-type="bibr" rid="pntd.0004903.ref058">58</xref>]. Furthermore this lytic activity of Papio APOL1 against <italic>T</italic>. <italic>b</italic>. <italic>rhodesiense</italic> has been demonstrated to be the result of a single polymorphism [<xref ref-type="bibr" rid="pntd.0004903.ref062">62</xref>]. We therefore hypothesize that the broad lytic ability of <italic>P</italic>. <italic>papio</italic> may be attributable to a functional variant of this protein. Sequenced <italic>APOL1</italic> cDNA was used as a template for the production of recombinant variants of <italic>P</italic>. <italic>papio</italic> and human APOL1 protein (<xref ref-type="supplementary-material" rid="pntd.0004903.s003">S3 Fig</xref>-Amino acid alignment). Representative strains of the different <italic>T</italic>. <italic>brucei</italic> sub-species were incubated in the presence of purified <italic>P</italic>. <italic>papio</italic> and human recombinant protein to determine if APOL1 alone had demonstrable trypanolytic ability. Titrated human recombinant APOL1 protein completely lysed <italic>T</italic>. <italic>b</italic>. <italic>brucei</italic> parasites after 24 hours (IC<sub>50</sub>; 1.013 μg/ml), at concentrations comparable to the physiological levels of APOL1 reported for normal human serum [<xref ref-type="bibr" rid="pntd.0004903.ref074">74</xref>–<xref ref-type="bibr" rid="pntd.0004903.ref076">76</xref>], but had no lytic effect on strains of the human serum resistant parasites, <italic>T</italic>. <italic>b</italic>. <italic>rhodesiense</italic>, <italic>T</italic>. <italic>b</italic>. <italic>gambiense</italic> group 1 or <italic>T</italic>. <italic>b</italic>. <italic>gambiense</italic> group 2 (<xref ref-type="fig" rid="pntd.0004903.g002">Fig 2A</xref>). In contrast, recombinant <italic>P</italic>. <italic>papio</italic> APOL1 protein exhibited trypanolytic activity against representative strains of all <italic>T</italic>. <italic>brucei</italic> sub-species (<xref ref-type="fig" rid="pntd.0004903.g002">Fig 2B</xref> with additional <italic>T</italic>. <italic>b</italic>. <italic>gambiense</italic> group 1 strains assays provided in <xref ref-type="supplementary-material" rid="pntd.0004903.s004">S4 Fig</xref>). Furthermore, strains of all sub-species tested appeared equally susceptible to the effect of recombinant <italic>P</italic>. <italic>papio</italic> APOL1, with no significant difference in IC<sub>50</sub> observed (one-way ANOVA, F (3, 24) = 1.741, <italic>p</italic> = 0.19). Notably, as has been observed for human APOL1, this lytic activity is inhibited by the addition of the acidotropic agent ammonium chloride to the assay (<xref ref-type="fig" rid="pntd.0004903.g002">Fig 2A and 2B</xref>). Ammonium chloride is a weak base that raises endolysosomal pH, thereby preventing pH-dependant conformational changes to APOL1 that are predicted to be essential to efficient ion-channel mediated lysis [<xref ref-type="bibr" rid="pntd.0004903.ref032">32</xref>,<xref ref-type="bibr" rid="pntd.0004903.ref034">34</xref>,<xref ref-type="bibr" rid="pntd.0004903.ref077">77</xref>]. This corresponding inhibition of APOL1-mediated lysis for both orthologs is further indicative of a conserved mechanism of action. In summary these assays demonstrate that the <italic>P</italic>. <italic>papio</italic> APOL1 ortholog in isolation exhibits trypanolytic ability against all tested examples of the human-infective <italic>T</italic>. <italic>brucei</italic> sub-species. Although there may be other, as yet uncharacterized factors that contribute to the lytic ability of <italic>P</italic>. <italic>papio</italic> serum, the APOL1 ortholog is a significant trypanolytic component.</p>
<fig id="pntd.0004903.g002" position="float">
<object-id pub-id-type="doi">10.1371/journal.pntd.0004903.g002</object-id>
<label>Fig 2</label>
<caption>
<title>Trypanolytic activity of recombinant APOL1.</title>
<p>The percentage of viable trypanosomes was determined following a 24-hour exposure to media containing serial dilutions of A) recombinant Human APOL1 protein and B) recombinant <italic>P</italic>. <italic>papio</italic> APOL1 protein. Representative <italic>T</italic>. <italic>brucei</italic> sub-species strains were tested: <italic>T</italic>. <italic>b</italic>. <italic>brucei</italic> (strain STIB247), <italic>T</italic>. <italic>b</italic>. <italic>rhodesiense</italic> (strain EATRO98), <italic>T</italic>. <italic>b</italic>. <italic>gambiense</italic> group 1 (strain ELIANE), and <italic>T</italic>. <italic>b</italic>. <italic>gambiense</italic> group 2 (strain STIB386). Additional assays were performed with different strains of <italic>T</italic>. <italic>b</italic>. <italic>gambiense</italic> group 1 and are provided in <xref ref-type="supplementary-material" rid="pntd.0004903.s004">S4 Fig</xref>. The mean percentage cell survival ± SD, relative to protein-free control, was calculated from at least three independent experiments. Dose–response curves and IC<sub>50</sub> values with 95% confidence intervals (CI) were determined using GraphPad Prism software version 7. APOL1-mediated lysis of each isolate was prevented by the inclusion of an acidotropic agent (10 mM NH<sub>4</sub>Cl) in the assay.</p>
</caption>
<graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pntd.0004903.g002" xlink:type="simple"/>
</fig>
</sec>
<sec id="sec013">
<title><italic>T</italic>. <italic>b</italic>. <italic>gambiense</italic> group 1 HpHbR reduces sensitivity to <italic>P</italic>. <italic>papio</italic> serum lysis</title>
<p>A reduced sensitivity to lysis was observed for both the predominant <italic>T</italic>. <italic>b</italic>. <italic>gambiense</italic> group 1 and minor group 2 strains, relative to <italic>T</italic>. <italic>b</italic>. <italic>brucei</italic> and <italic>T</italic>. <italic>b</italic>. <italic>rhodesiense</italic>, when incubated with <italic>P</italic>. <italic>papio</italic> <bold>serum</bold>, but not recombinant APOL1 <bold>protein</bold>. We postulated that for <italic>T</italic>. <italic>b</italic>. <italic>gambiense</italic> group 1, this difference might be the result of disparity in the rate of uptake of APOL1 versus APOL1–containing trypanolytic factors by these parasites. In normal human serum, HPR bound to haemoglobin, acts as ligand to facilitate TLF-1 uptake via the <italic>T</italic>. <italic>brucei</italic> HpHbR receptor [<xref ref-type="bibr" rid="pntd.0004903.ref023">23</xref>,<xref ref-type="bibr" rid="pntd.0004903.ref078">78</xref>]. However, a defining feature of <italic>T</italic>. <italic>b</italic>. <italic>gambiense</italic> group 1 strains is a decrease in TLF-1 internalisation as a result of reduced <italic>HpHbR</italic> expression and a conserved L210S substitution that reduces the binding affinity of HpHbR for its ligand [<xref ref-type="bibr" rid="pntd.0004903.ref050">50</xref>,<xref ref-type="bibr" rid="pntd.0004903.ref079">79</xref>]. Reduced TLF uptake via HpHbR contributes to the invariant human serum resistant phenotype of these parasites, although alone is insufficient to impart resistance to human serum [<xref ref-type="bibr" rid="pntd.0004903.ref078">78</xref>] due to the existence of other speculated receptors for TLF-1 [<xref ref-type="bibr" rid="pntd.0004903.ref080">80</xref>,<xref ref-type="bibr" rid="pntd.0004903.ref081">81</xref>], and the additional TLF-2 particle in human serum for which the uptake mechanisms remain unknown [<xref ref-type="bibr" rid="pntd.0004903.ref021">21</xref>,<xref ref-type="bibr" rid="pntd.0004903.ref082">82</xref>,<xref ref-type="bibr" rid="pntd.0004903.ref083">83</xref>]. In contrast, recombinant APOL1 is internalised by non-specific fluid phase endocytosis and trafficked through the endolysosome pathway, thus completely circumventing the HpHbR receptor [<xref ref-type="bibr" rid="pntd.0004903.ref027">27</xref>,<xref ref-type="bibr" rid="pntd.0004903.ref048">48</xref>].</p>
<p>The number of molecules in the TLF complex and its exact structural composition in baboon serum is currently unresolved, but a representative baboon species, <italic>P</italic>. <italic>hamadryas</italic>, has been demonstrated to have similar constitutive components (HPR and APOL1) to human TLF [<xref ref-type="bibr" rid="pntd.0004903.ref014">14</xref>]. As <italic>T</italic>. <italic>b</italic>. <italic>gambiense</italic> group 1 parasites have a reduced uptake of human TLF-1 but the other subspecies do not we postulated that a similar mechanism could reduce the uptake of <italic>P</italic>. <italic>papio</italic> TLF particles by <italic>T</italic>. <italic>b</italic>. <italic>gambiense</italic> group 1 strains, which is corrected by direct incubation in recombinant APOL1 protein. To investigate this we repeated the serum resistance assays using a <italic>T</italic>. <italic>b</italic>. <italic>gambiense</italic> ELIANE strain expressing a functional <italic>T</italic>. <italic>b</italic>. <italic>brucei</italic> HpHbR receptor (ELIANE <italic>TbbHpHbR</italic> <sup><italic>-/+</italic></sup>), that was previously generated by our laboratory and demonstrated to take up comparable amounts of TLF-1 to <italic>T</italic>. <italic>b</italic>. <italic>brucei</italic> [<xref ref-type="bibr" rid="pntd.0004903.ref051">51</xref>]. As previously observed, expression of the functional <italic>T</italic>. <italic>b</italic>. <italic>brucei</italic> HpHbR receptor alone was insufficient to convert the phenotype of <italic>T</italic>. <italic>b</italic>. <italic>gambiens</italic>e to human serum sensitivity and this clone (<italic>TbbHpHbR</italic> <sup><italic>-/+</italic></sup> <italic>T</italic>. <italic>b</italic>. <italic>gambiense</italic>) retains full resistance to normal human serum (<xref ref-type="fig" rid="pntd.0004903.g003">Fig 3A</xref>). However, it exhibits a 1000-fold increased sensitivity to <italic>P</italic>. <italic>papio</italic> serum (relative to the wild-type <italic>T</italic>. <italic>b</italic>. <italic>gambiense</italic> group 1 ELIANE strain), producing an IC<sub>50</sub> value (0.0005%) comparable to that observed for the <italic>T</italic>. <italic>b</italic>. <italic>brucei</italic> and <italic>T</italic>. <italic>b</italic>. <italic>rhodesiense</italic> sub-species (<xref ref-type="fig" rid="pntd.0004903.g003">Fig 3B</xref> and <xref ref-type="supplementary-material" rid="pntd.0004903.s002">S2 Fig</xref>). Taken together, the serum and APOL1 assays indicate that diminished TLF uptake via the HpHbR receptor, rather than higher innate resistance to <italic>P</italic>. <italic>papio</italic> APOL1-mediated lysis underlies the increased resistance to <italic>P</italic>. <italic>papio</italic> serum observed for <italic>T</italic>. <italic>b</italic>. <italic>gambiense</italic> group 1 strains.</p>
<fig id="pntd.0004903.g003" position="float">
<object-id pub-id-type="doi">10.1371/journal.pntd.0004903.g003</object-id>
<label>Fig 3</label>
<caption>
<title>Expression of <italic>T</italic>. <italic>b</italic>. <italic>brucei HpHbR</italic> in <italic>T</italic>. <italic>b</italic>. <italic>gambiense</italic> group 1 increases sensitivity to <italic>P</italic>. <italic>papio</italic> serum lysis.</title>
<p>The percentage of viable trypanosomes following a 24-hour exposure to serial dilutions of A) human serum and B) <italic>P</italic>. <italic>papio</italic> serum was determined for <italic>T</italic>. <italic>b</italic>. <italic>gambiense</italic> (strain ELIANE) and <italic>T</italic>. <italic>b</italic>. <italic>gambiense</italic> expressing a functional <italic>T</italic>. <italic>b</italic>. <italic>brucei HpHbR</italic> receptor (strain ELIANE <italic>TbbHpHbR</italic><sup><italic>-/+</italic></sup>) alongside representative <italic>T</italic>. <italic>brucei</italic> sub-species strains <italic>T</italic>. <italic>b</italic>. <italic>brucei</italic> (STIB247) and <italic>T</italic>. <italic>b</italic>. <italic>rhodesiense</italic> (EATRO98). Mean percentage cell survival ± SD is expressed, relative to FBS control. Dose–response curves and IC<sub>50</sub> values with 95% confidence intervals (CI) were determined using GraphPad Prism software version 7.</p>
</caption>
<graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pntd.0004903.g003" xlink:type="simple"/>
</fig>
<p>In <italic>T</italic>. <italic>b</italic>. <italic>gambiense</italic> group 2, in contrast, an as yet uncharacterised HpHbR–independent mechanism/s determines human infectivity. <italic>T</italic>. <italic>b</italic>. <italic>gambiense</italic> group 2 strains, including the STIB386 isolate used in this study, have been shown to express the <italic>HpHbR</italic> gene at level comparable with <italic>T</italic>. <italic>b</italic>. <italic>brucei</italic>, with no demonstrable reduction in TLF-1 uptake [<xref ref-type="bibr" rid="pntd.0004903.ref048">48</xref>]. Consequently, the reduced sensitivity to <italic>P</italic>. <italic>papio</italic> serum lysis, but not APOL1 protein, also observed for these HpHbR-functional parasites, further indicates that important differences exist in the cell biology of between <italic>T</italic>. <italic>b</italic>. <italic>gambiense</italic> group 2 and <italic>T</italic>. <italic>b</italic>. <italic>gambiense</italic> group 1 strains that determine sensitivity to these primate lytic factors.</p>
</sec>
<sec id="sec014">
<title>Localisation of <italic>P</italic>. <italic>papio</italic> APOL1</title>
<p>Human recombinant APOL1 is taken up by fluid phase endocytosis and trafficked through the endocytic pathway to the endolysosome, the initial activation site of APOL1, in all <italic>T</italic>. <italic>brucei</italic> sub-species [<xref ref-type="bibr" rid="pntd.0004903.ref027">27</xref>,<xref ref-type="bibr" rid="pntd.0004903.ref048">48</xref>]. This results in lysis of <italic>T</italic>. <italic>b</italic>. <italic>brucei</italic> but not of <italic>T</italic>. <italic>b</italic>. <italic>rhodesiense</italic> or <italic>T</italic>. <italic>b</italic>. <italic>gambiense</italic> [<xref ref-type="bibr" rid="pntd.0004903.ref048">48</xref>], which each possess mechanisms to resist the lytic effects of APOL1 [<xref ref-type="bibr" rid="pntd.0004903.ref035">35</xref>,<xref ref-type="bibr" rid="pntd.0004903.ref048">48</xref>,<xref ref-type="bibr" rid="pntd.0004903.ref051">51</xref>,<xref ref-type="bibr" rid="pntd.0004903.ref052">52</xref>]. To determine if <italic>P</italic>. <italic>papio</italic> APOL1 is localised through the parasite endolysosome pathway in a similar manner to that demonstrated for human APOL1, uptake of both recombinant proteins was compared in <italic>T</italic>. <italic>b</italic>. <italic>brucei</italic> and <italic>T</italic>. <italic>b</italic>. <italic>gambiense</italic> group 1 parasites using a fluorescent antibody to detect the His-tagged recombinant APOL1 protein. The cells were then examined by microscopy, in conjunction with the lysosomal marker p67. In order to achieve images of APOL1 uptake we used high concentrations of APOL1 (material and methods) to counteract possible degradation of APOL1 in the lysosome. Consistent with previous experiments of serum and APOL1 uptake in our laboratory [<xref ref-type="bibr" rid="pntd.0004903.ref048">48</xref>,<xref ref-type="bibr" rid="pntd.0004903.ref049">49</xref>,<xref ref-type="bibr" rid="pntd.0004903.ref051">51</xref>], no lysosomal swelling was observed. As shown in <xref ref-type="fig" rid="pntd.0004903.g004">Fig 4</xref>, both human and <italic>P</italic>. <italic>papio</italic> APOL1 are internalised by <italic>T</italic>. <italic>b</italic>. <italic>brucei</italic> and <italic>T</italic>. <italic>b</italic>. <italic>gambiense</italic> after a two hour incubation and are observed to co-localise with an antibody directed against the lysosomal membrane protein p67, indicative of the parasite endolysosome pathway [<xref ref-type="bibr" rid="pntd.0004903.ref084">84</xref>,<xref ref-type="bibr" rid="pntd.0004903.ref085">85</xref>]. These observations, in parallel with the ablation of lysis observed after co-incubation with acidotropic agent, ammonium chloride in APOL1 lysis assays, suggest that as previously demonstrated for human APOL1, exposure of the protein to the low pH of the endolysosomal pathway is also a requirement for trypanolytic activity of the baboon APOL1 ortholog.</p>
<fig id="pntd.0004903.g004" position="float">
<object-id pub-id-type="doi">10.1371/journal.pntd.0004903.g004</object-id>
<label>Fig 4</label>
<caption>
<title>Recombinant APOL1 uptake and localisation.</title>
<p>The localisation of Alexa488 (green) labelled anti-pentaHis antibody (APOL1), AlexaFluor594 (red) labelled anti-p67 (lysosomal membrane protein) and DAPI after a two-hour exposure to recombinant Human and <italic>P</italic>. <italic>papio</italic> APOL1 featuring an N-terminal 6xHis-tag. The panels represent human serum sensitive <italic>T</italic>. <italic>b</italic>. <italic>brucei</italic>, strain STIB247, and human serum resistant <italic>T</italic>. <italic>b</italic>. <italic>gambiense</italic> group 1, strain ELIANE.</p>
</caption>
<graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pntd.0004903.g004" xlink:type="simple"/>
</fig>
</sec>
</sec>
<sec id="sec015" sec-type="conclusions">
<title>Discussion</title>
<p>The ancient co-evolutionary engagement of African trypanosomes with their mammalian hosts has shaped an innate lytic molecule in man that protects from infection with most African trypanosomes. In response, the extensive antigenic repertoire of <italic>T</italic>. <italic>brucei</italic> [<xref ref-type="bibr" rid="pntd.0004903.ref086">86</xref>] has provided a rich resource from which to evolve counter-measures to APOL1-mediated lysis on at least two occasions; <italic>SRA</italic> in <italic>T</italic>. <italic>b</italic>. <italic>rhodesiense</italic> in East Africa [<xref ref-type="bibr" rid="pntd.0004903.ref035">35</xref>,<xref ref-type="bibr" rid="pntd.0004903.ref036">36</xref>,<xref ref-type="bibr" rid="pntd.0004903.ref087">87</xref>], and <italic>TgsGP</italic> in <italic>T</italic>. <italic>b</italic>. <italic>gambiense</italic> group 1 in West Africa [<xref ref-type="bibr" rid="pntd.0004903.ref051">51</xref>,<xref ref-type="bibr" rid="pntd.0004903.ref052">52</xref>,<xref ref-type="bibr" rid="pntd.0004903.ref088">88</xref>]. In this study we present a novel APOL1 variant from a species of West African baboon that killed examples of all <italic>T</italic>. <italic>brucei</italic> sub-species, including <italic>T</italic>. <italic>b</italic>. <italic>rhodesiense</italic>, <italic>T</italic>. <italic>b</italic>. <italic>gambiense</italic> group 2, and <italic>T</italic>. <italic>b</italic>. <italic>gambiense</italic> group 1, the agent of most current cases of human African trypanosomiasis. The identification of such genetic variants, capable of killing both animal and human-infective parasites presents new opportunities for unconventional approaches to disease treatment and control, using APOL1-based biological therapies.</p>
<p>Previous studies have identified <italic>APOL1</italic> orthologs in a subset of Old World monkeys [<xref ref-type="bibr" rid="pntd.0004903.ref014">14</xref>,<xref ref-type="bibr" rid="pntd.0004903.ref062">62</xref>], and an <italic>APOL1</italic> variant with a key similarity in some humans with African ancestry [<xref ref-type="bibr" rid="pntd.0004903.ref063">63</xref>], that encode proteins lytic to <italic>T</italic>. <italic>b</italic>. <italic>rhodesiense</italic>. In both variants, evidence suggests protection is mediated by the position of a single lysine residue in the C-terminal protein domain that obstructs coiled-coil interactions with SRA, thus allowing APOL1-directed lysis to proceed unimpeded [<xref ref-type="bibr" rid="pntd.0004903.ref062">62</xref>]. Unfortunately in humans, the two amino acid deletion that alters the SRA-binding region in this APOL1-G2 variant come with an associated fitness cost: a 7–29-fold increased risk of developing a wide spectrum of kidney disorders in individuals carrying two copies of a variant allele [<xref ref-type="bibr" rid="pntd.0004903.ref063">63</xref>,<xref ref-type="bibr" rid="pntd.0004903.ref089">89</xref>–<xref ref-type="bibr" rid="pntd.0004903.ref092">92</xref>]. The exact biological mechanism underlying this APOL1-associated nephropathy is not yet known but appears to be specific to the human variants. Engineered versions of the human APOL1 variant transiently expressed in a mouse model caused significant toxicity to the organ of expression (liver), which was not observed with baboon APOL1 or human APOL1 modified to introduce only the protective baboon lysine to the C-terminus [<xref ref-type="bibr" rid="pntd.0004903.ref062">62</xref>]. This is an encouraging result, and such baboon-like APOL1 variants are now the focus of efforts to create suitable mechanisms of delivery, such as the conjugation of APOL1 protein to an antibody fragment targeted to parasite surface antigens [<xref ref-type="bibr" rid="pntd.0004903.ref093">93</xref>] and an ambitious project to create targeted transgenic cattle expressing variant APOL1 [<xref ref-type="bibr" rid="pntd.0004903.ref015">15</xref>].</p>
<p>These variants could be used to protect the reservoir host species from zoonotic <italic>T</italic>. <italic>b</italic>. <italic>rhodesiense</italic> sleeping sickness in addition to animal trypanosomiasis, which places severe restrictions on agricultural production and rural development in Sub-Saharan Africa [<xref ref-type="bibr" rid="pntd.0004903.ref001">1</xref>]. Unfortunately, they will have a limited effect on the overall burden of human sleeping sickness. None of the APOL1 variants used in these experiments are able to kill the major human pathogen <italic>T</italic>. <italic>b</italic>. <italic>gambiense</italic> group 1 which places a population of 57 million people in West and Central Africa at risk of disease [<xref ref-type="bibr" rid="pntd.0004903.ref004">4</xref>], less than 5% of whom are currently under surveillance [<xref ref-type="bibr" rid="pntd.0004903.ref094">94</xref>]. Furthermore, there is a risk that the proposed interventions could result in the creation of a vacant ecological niche that increases the incidence of <italic>T</italic>. <italic>b</italic>. <italic>gambiense</italic> group 1 in domestic livestock through selective removal of susceptible competitor species such as <italic>T</italic>. <italic>b</italic>. <italic>brucei</italic>, <italic>T</italic>. <italic>congolense</italic>, <italic>T</italic>. <italic>vivax</italic> and <italic>T</italic>. <italic>b</italic>. <italic>rhodesiense</italic>.</p>
<p>We have addressed these concerns directly in this study by examining the serum of a West African baboon species <italic>P</italic>. <italic>papio</italic> that overlaps in distribution with that of <italic>T</italic>. <italic>b</italic>. <italic>gambiense</italic>, and which had been suggested to self-cure <italic>T</italic>. <italic>b</italic>. <italic>gambiense</italic> group 1 infection [<xref ref-type="bibr" rid="pntd.0004903.ref064">64</xref>]. In that study primates infected with <italic>T</italic>. <italic>b</italic>. <italic>gambiense</italic> group 1 parasites exhibited a serological response that decreased throughout the course of the experiment and had no detectable parasitemia, consistent with an initial infection, followed by rapid parasite clearance and self-cure. In our study <italic>P</italic>. <italic>papio</italic> serum is able to lyse <italic>T</italic>. <italic>b</italic>. <italic>gambiense</italic> in 24 hours <italic>in vitro</italic>. The difference in timing of parasite killing between the <italic>in vivo</italic> and <italic>in vitro</italic> experiments, which could be due to a number of different factors such as parasite sequestration, is a well-recognised phenomenon. It is possible that parasites avoid lysis by residing in sites of low APOL1 concentrations (for example at the bite site in the skin) in the animal before eventually being cleared. This factor must be taken into account when attempting to develop APOL1-based therapies as <italic>in vitro</italic> assays do not always reflect the complexity of <italic>in vivo</italic> cell biology. The introduction of improved bioluminescent imaging to quantify parasite burden could be used to test <italic>in vivo</italic> for complete parasite clearance.</p>
<p>We have shown that the lytic effect of <italic>P</italic>. <italic>papio</italic> serum can be reproduced with an ortholog of the trypanolytic primate defence protein, APOL1, which demonstrates the uptake and localisation characteristics of other previously identified APOL1 proteins [<xref ref-type="bibr" rid="pntd.0004903.ref027">27</xref>,<xref ref-type="bibr" rid="pntd.0004903.ref048">48</xref>]. The trypanolytic action of this <italic>P</italic>. <italic>papio</italic> APOL1 variant against <italic>T</italic>. <italic>b</italic>. <italic>rhodesiense</italic> can be attributed to the C-terminal lysine mutation that is conserved among several members of the Cercopithecine subfamily that includes baboon, mandrills and mangabeys [<xref ref-type="bibr" rid="pntd.0004903.ref062">62</xref>]. However the mechanism by which it counters <italic>T</italic>. <italic>b</italic>. <italic>gambiense</italic>, which has evolved multiple contributing mechanisms of human serum resistance, remains more elusive. All <italic>T</italic>. <italic>b</italic>. <italic>gambiense</italic> group 1 parasites share a mutated <italic>HpHbR</italic> with reduced affinity for one of the human APOL1-containing particles (TLF-1) via the HPR ligand [<xref ref-type="bibr" rid="pntd.0004903.ref048">48</xref>–<xref ref-type="bibr" rid="pntd.0004903.ref050">50</xref>], although a second particle, TLF2, appears to have alternative, as yet unresolved, mechanism(s) of internalisation [<xref ref-type="bibr" rid="pntd.0004903.ref024">24</xref>,<xref ref-type="bibr" rid="pntd.0004903.ref080">80</xref>,<xref ref-type="bibr" rid="pntd.0004903.ref081">81</xref>,<xref ref-type="bibr" rid="pntd.0004903.ref083">83</xref>]. The exact composition of TLF in baboon serum has not been clarified. However analysis of an HPR-affinity purified HDL sub-fraction from <italic>P</italic>. <italic>hamadryas</italic> baboon serum detected a TLF-equivalent particle that contains the same structural components as human TLF [<xref ref-type="bibr" rid="pntd.0004903.ref014">14</xref>]. Furthermore, when transiently expressed in mice, all three components were required for maximum lytic activity against <italic>T</italic>. <italic>b</italic>. <italic>rhodesiense</italic> [<xref ref-type="bibr" rid="pntd.0004903.ref014">14</xref>], suggesting HPR-HpHbR may play a role in uptake of baboon TLF. Here we show that <italic>T</italic>. <italic>b</italic>. <italic>gambiense</italic> group 1, although still fully susceptible to sub-physiological concentrations of <italic>P</italic>. <italic>papio</italic> serum, was 1000-fold less sensitive than <italic>T</italic>. <italic>b</italic>. <italic>brucei</italic> sub-species. This difference was ablated when functional <italic>T</italic>. <italic>b</italic>. <italic>brucei</italic> HpHbR was restored to the <italic>T</italic>. <italic>b</italic>. <italic>gambiense</italic> parasite, supporting a role for <italic>P</italic>. <italic>papio</italic> TLF uptake via both HpHbR-mediated endocytosis as well as unidentified alternative mechanisms, possible shared with those already proposed for human TLF [<xref ref-type="bibr" rid="pntd.0004903.ref024">24</xref>,<xref ref-type="bibr" rid="pntd.0004903.ref080">80</xref>,<xref ref-type="bibr" rid="pntd.0004903.ref081">81</xref>,<xref ref-type="bibr" rid="pntd.0004903.ref083">83</xref>].</p>
<p>Secondly, the <italic>TgsGP</italic> gene has been demonstrated to be essential for human serum resistance in <italic>T</italic>. <italic>b</italic>. <italic>gambiense</italic> group 1, as gene deletion renders the parasites sensitive to human serum lysis [<xref ref-type="bibr" rid="pntd.0004903.ref051">51</xref>,<xref ref-type="bibr" rid="pntd.0004903.ref052">52</xref>]. In contrast to the <italic>T</italic>. <italic>b</italic>. <italic>rhodesiense</italic> SRA protein, TgsGP and APOL1 do not appear to interact directly. Instead, TgsGP is proposed to bolster <italic>T</italic>. <italic>b</italic>. <italic>gambiense</italic> resistance to human APOL1 pore-forming activity through a process of plasma membrane stiffening [<xref ref-type="bibr" rid="pntd.0004903.ref052">52</xref>]. A third mechanism by which <italic>T</italic>. <italic>b</italic>. <italic>gambiense</italic> might resist the actions of NHS, through enhanced APOL1 degradation within the endolysosomal system, has also been proposed [<xref ref-type="bibr" rid="pntd.0004903.ref052">52</xref>]. Modulation of expression levels of the cysteine protease Cathepsin L and its inhibitor (ICP) has demonstrated an important role for cathepsin-mediated degradation of APOL1 in human serum resistance [<xref ref-type="bibr" rid="pntd.0004903.ref053">53</xref>]. Difference in expression levels of these genes has not been detected in <italic>T</italic>. <italic>b</italic>. <italic>gambiense</italic>, however a lower pH is observed within the early endosomes that is predicted to accelerate their proteolytic activity relative to <italic>T</italic>. <italic>b</italic>. <italic>brucei</italic> [<xref ref-type="bibr" rid="pntd.0004903.ref052">52</xref>]. Intriguingly, we observed equal sensitivity of all strains tested to <italic>P</italic>. <italic>papio</italic> APOL1-directed lysis, suggesting that the activity of TgsGP, and APOL1 degradation by cysteine peptidases, that effectively hinders human APOL1 in <italic>T</italic>. <italic>b</italic>. <italic>gambiense</italic>, poses no such barrier to the <italic>P</italic>. <italic>papio</italic> variant. This raises interesting questions about how exactly <italic>P</italic>. <italic>papio</italic> APOL1 is able to overcome these factors? Many details of the action of the TgsGP protein in particular remain cryptic. Despite its essential role in human serum resistance in <italic>T</italic>. <italic>b</italic>. <italic>gambiense</italic>, ectopic expression of <italic>T</italic>. <italic>b</italic>. <italic>gambiense</italic> TgsGP alone in <italic>T</italic>. <italic>b</italic>. <italic>brucei</italic> is insufficient to confer resistance to human serum [<xref ref-type="bibr" rid="pntd.0004903.ref051">51</xref>,<xref ref-type="bibr" rid="pntd.0004903.ref088">88</xref>]. There is evidently a role for other, as yet unidentified processes, in <italic>T</italic>. <italic>b</italic>. <italic>gambiense</italic> human serum resistance, which are absent or incomplete in <italic>T</italic>. <italic>b</italic>. <italic>brucei</italic>.</p>
<p>Sequence analysis has revealed that baboon and human APOL1 orthologs share only 58% amino acid sequence identity [<xref ref-type="bibr" rid="pntd.0004903.ref014">14</xref>]. Despite this, in the recently elucidated example of baboon serum lysis of <italic>T</italic>. <italic>b</italic>. <italic>rhodesiense</italic> it was demonstrated that a single amino acid substitution conserved between baboon species is responsible for APOL1 evasion of SRA binding [<xref ref-type="bibr" rid="pntd.0004903.ref062">62</xref>]. Uncovering the mechanism by which <italic>P</italic>. <italic>papio</italic> has developed its broad trypanolytic ability may offer further insights into the workings of <italic>T</italic>. <italic>b</italic>. <italic>gambiense</italic> human serum resistance, as well as aid in the design of an improved APOL1 therapy that could target all pathogenic trypanosomes across Sub-Saharan Africa. Such universal therapies that can treat both animal and human pathogens are particularly appropriate to the “one health” approach, currently advocated by WHO, FAO, and OIE, that integrates medical and veterinary health policy and research for addressing zoonotic diseases.</p>
<p>The Guinea baboon <italic>P</italic>. <italic>papio</italic> is found only in a limited area of western equatorial Africa, where its range overlaps with that of <italic>T</italic>. <italic>b</italic>. <italic>gambiense</italic> group 1. Five other baboons are represented in the <italic>Papio</italic> genus of which serum for only one, the east African <italic>P</italic>. <italic>cynocephalu</italic>s (yellow baboon) has been previously tested against <italic>T</italic>. <italic>b</italic>. <italic>gambiense</italic> parasites, and was reported to be non–lytic [<xref ref-type="bibr" rid="pntd.0004903.ref037">37</xref>]. Unfortunately APOL1 sequence is currently unavailable for comparative analysis with this species or the southern African <italic>P</italic>. <italic>ursinus</italic> (Chacma baboon) and <italic>P</italic>. <italic>kindae</italic> (Kinda baboon) species from Central Africa. Of the remaining <italic>Papio</italic> species, APOL1 sequences from cDNA have been successfully obtained for <italic>P</italic>. <italic>hamadryas</italic> (Hamadryas baboon) from North East Africa, and Central African <italic>P</italic>. <italic>anubis</italic> (Olive baboon) [<xref ref-type="bibr" rid="pntd.0004903.ref062">62</xref>], the closest related species to <italic>P</italic>. <italic>papio</italic> in a recent phylogenetic study of mitochondrial DNA [<xref ref-type="bibr" rid="pntd.0004903.ref095">95</xref>]. Amino acid alignments of <italic>P</italic>. <italic>papio</italic> APOL1 with these available sequences indicate ~98.5% identity to <italic>P</italic>. <italic>hamadryas</italic> and 93.5% to <italic>P</italic>. <italic>anubis</italic> (<xref ref-type="supplementary-material" rid="pntd.0004903.s003">S3 Fig</xref>). A study in which C-terminal polymorphisms of <italic>P</italic>. <italic>anubis</italic> were incorporated into human recombinant APOL1 were observed to be lytic to <italic>T</italic>. <italic>b</italic>. <italic>rhodesiense</italic> but not <italic>T</italic>. <italic>b</italic>. <italic>gambiense</italic> [<xref ref-type="bibr" rid="pntd.0004903.ref037">37</xref>], however full length APOL1 transcripts, unavailable at the time of the study, have not been tested. For <italic>P</italic>. <italic>hamadryas</italic>, serum and APOL1 have not yet been tested against <italic>T</italic>. <italic>b</italic>. <italic>gambiense</italic>, however a laboratory infection of two individual baboons with a strain of <italic>T</italic>. <italic>b</italic>. <italic>gambiense</italic> group 1 suggested hamadryas baboons to display a level of trypanotolerance to infection [<xref ref-type="bibr" rid="pntd.0004903.ref064">64</xref>]. Future studies in which the sensitivity of <italic>T</italic>. <italic>brucei</italic> subspecies to serum and APOL1 from the other baboon species, followed by the construction of chimera mutants are now needed to help resolve the crucial polymorphisms responsible for <italic>T</italic>. <italic>b</italic>. <italic>gambiense</italic> lysis, as has been successful for <italic>T</italic>. <italic>b</italic>. <italic>rhodesiense</italic>.</p>
</sec>
<sec id="sec016">
<title>Supporting Information</title>
<supplementary-material id="pntd.0004903.s001" mimetype="image/tiff" position="float" xlink:href="info:doi/10.1371/journal.pntd.0004903.s001" xlink:type="simple">
<label>S1 Fig</label>
<caption>
<title>Purification of recombinant human and <italic>P</italic>. <italic>papio</italic> APOL1 protein variants.</title>
<p>APOL1 variants were produced in <italic>E</italic>. <italic>coli</italic>, based on <italic>APOL1</italic> cDNA sequence <italic>H</italic>. <italic>sapiens</italic> (accession no. CCDS13926.1) and <italic>P</italic>. <italic>papio</italic> (accession no. KC197810), minus the N-terminal signal peptide (<italic>H</italic>. <italic>sapiens</italic>, residues 28–398; <italic>P</italic>. <italic>papio</italic>, residues 28–288) and with the addition of an N-terminal 6xHis-tag. Proteins were purified using Ni-Sepharose under denaturing conditions and dialyzed against 20mM acetic acid and 0.05% tween. Purity and concentration of the final purified protein was checked using a Qubit fluorometer (Thermofisher) and SDS-PAGE (P = <italic>P</italic>. <italic>papio</italic>, H = human APOL1) stained with Brilliant blue G solution (Sigma-Aldrich) alongside SeeBlue Plus2 protein standards (Thermofisher). APOL1 concentration was adjusted to 1 mg/ml and stored in aliquots at 4°C.</p>
<p>(TIF)</p>
</caption>
</supplementary-material>
<supplementary-material id="pntd.0004903.s002" mimetype="image/tiff" position="float" xlink:href="info:doi/10.1371/journal.pntd.0004903.s002" xlink:type="simple">
<label>S2 Fig</label>
<caption>
<title>Trypanolytic activity of serum from an adult male Guinea baboon (<italic>P</italic>. <italic>papio)</italic> against representative examples of <italic>T</italic>. <italic>brucei</italic> sub-species.</title>
<p>To confirm the lytic ability of <italic>P</italic>. <italic>papio</italic> sera, the percentage of viable trypanosomes was determined following a 24-hour exposure to serial dilutions of an alternative Guinea baboon serum, sourced from an individual adult male (Matrix Biologicals, UK). Representative <italic>T</italic>. <italic>brucei</italic> sub-species strains were tested: <italic>T</italic>. <italic>b</italic>. <italic>brucei</italic> (strain STIB247), <italic>T</italic>. <italic>b</italic>. <italic>rhodesiense</italic> (strain EATRO98), <italic>T</italic>. <italic>b</italic>. <italic>gambiense</italic> group 1 (strain ELIANE) and <italic>T</italic>. <italic>b</italic>. <italic>gambiense</italic> group 1 expressing a functional <italic>T</italic>. <italic>b</italic>. <italic>brucei</italic> HpHbR receptor (ELIANE <italic>TbbHpHbR</italic> <sup><italic>-/+</italic></sup>). Mean percentage cell survival ± SD is expressed relative to FBS control, calculated from three independent experiments. Dose–response curves and IC<sub>50</sub> values with 95% confidence intervals (CI) were determined using GraphPad Prism software version 7.</p>
<p>(TIF)</p>
</caption>
</supplementary-material>
<supplementary-material id="pntd.0004903.s003" mimetype="image/tiff" position="float" xlink:href="info:doi/10.1371/journal.pntd.0004903.s003" xlink:type="simple">
<label>S3 Fig</label>
<caption>
<title>Amino acid alignment of Human and baboon APOL1 orthologs.</title>
<p>APOL1 amino acid sequence of the Old World monkey baboon species, <italic>Papio papio</italic>, was aligned with <italic>P</italic>. <italic>anubis</italic>, <italic>P</italic>. <italic>hamadryas</italic> and human (<italic>Homo sapiens</italic>) sequences. Dashes represent gaps introduced into the alignment by nucleotide deletions, and shading indicates amino acid differences. The position of the lysine (K) residue in the APOL1 C-terminus, implicated in resistance to <italic>T</italic>. <italic>b</italic>. <italic>rhodesiense</italic>, and present in several species of Old World monkey and the G2 APOL1 human variant is indicated (arrowhead).</p>
<p>(TIF)</p>
</caption>
</supplementary-material>
<supplementary-material id="pntd.0004903.s004" mimetype="image/tiff" position="float" xlink:href="info:doi/10.1371/journal.pntd.0004903.s004" xlink:type="simple">
<label>S4 Fig</label>
<caption>
<title>Trypanolytic activity of recombinant <italic>P</italic>. <italic>papio</italic> APOL1 protein against additional strains of <italic>T</italic>. <italic>b</italic>. <italic>gambiense</italic> group 1.</title>
<p>The percentage of viable trypanosomes was determined following a 24-hour exposure to media containing serial dilutions of <bold><italic>P</italic>. <italic>papio</italic></bold> recombinant APOL1 protein. <bold><italic>T</italic>. <italic>b</italic>. <italic>gambiense</italic></bold> group 1 strains (ELIANE, TOBO and S1/1/6 [Côte d'Ivoire], PA [Republic of the Congo], and BIM [Cameroon]) were tested. The mean percentage cell survival ± SD, relative to protein-free control, was calculated from at least three independent experiments. Dose–response curves were determined using GraphPad Prism software version 7.</p>
<p>(TIF)</p>
</caption>
</supplementary-material>
</sec>
</body>
<back>
<ack>
<p>We gratefully acknowledge Jay Bangs for provision of anti-p67 antibody.</p>
</ack>
<ref-list>
<title>References</title>
<ref id="pntd.0004903.ref001"><label>1</label><mixed-citation publication-type="other" xlink:type="simple">Food and Agriculture Organization. On target against poverty: the Programme Against African Trypanosomiasis (PAAT) 1997–2007. Rome; 2008.</mixed-citation></ref>
<ref id="pntd.0004903.ref002"><label>2</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Kennedy</surname> <given-names>PG</given-names></name>. <article-title>Clinical features, diagnosis, and treatment of human African trypanosomiasis (sleeping sickness)</article-title>. <source>Lancet Neurol</source>. <year>2013</year>;<volume>12</volume>: <fpage>186</fpage>–<lpage>194</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/S1474-4422(12)70296-X" xlink:type="simple">10.1016/S1474-4422(12)70296-X</ext-link></comment> <object-id pub-id-type="pmid">23260189</object-id></mixed-citation></ref>
<ref id="pntd.0004903.ref003"><label>3</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Brun</surname> <given-names>R</given-names></name>, <name name-style="western"><surname>Blum</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Chappuis</surname> <given-names>F</given-names></name>, <name name-style="western"><surname>Burri</surname> <given-names>C</given-names></name>. <article-title>Human African trypanosomiasis</article-title>. <source>Lancet</source>. Elsevier; <year>2010</year>;<volume>375</volume>: <fpage>148</fpage>–<lpage>159</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/S0140-6736(09)60829-1" xlink:type="simple">10.1016/S0140-6736(09)60829-1</ext-link></comment> <object-id pub-id-type="pmid">19833383</object-id></mixed-citation></ref>
<ref id="pntd.0004903.ref004"><label>4</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Simarro</surname> <given-names>PP</given-names></name>, <name name-style="western"><surname>Cecchi</surname> <given-names>G</given-names></name>, <name name-style="western"><surname>Franco</surname> <given-names>JR</given-names></name>, <name name-style="western"><surname>Paone</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Diarra</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Ruiz-Postigo</surname> <given-names>JA</given-names></name>, <etal>et al</etal>. <article-title>Estimating and mapping the population at risk of sleeping sickness. Ndung’u JM, editor</article-title>. <source>PLOS Negl Trop Dis</source>. Public Library of Science; <year>2012</year>;<volume>6</volume>: <fpage>e1859</fpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1371/journal.pntd.0001859" xlink:type="simple">10.1371/journal.pntd.0001859</ext-link></comment> <object-id pub-id-type="pmid">23145192</object-id></mixed-citation></ref>
<ref id="pntd.0004903.ref005"><label>5</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Barrett</surname> <given-names>MP</given-names></name>, <name name-style="western"><surname>Vincent</surname> <given-names>IM</given-names></name>, <name name-style="western"><surname>Burchmore</surname> <given-names>RJS</given-names></name>, <name name-style="western"><surname>Kazibwe</surname> <given-names>AJN</given-names></name>, <name name-style="western"><surname>Matovu</surname> <given-names>E</given-names></name>. <article-title>Drug resistance in human African trypanosomiasis</article-title>. <source>Future Microbiol</source>. Future Medicine Ltd London, UK; <year>2011</year>;<volume>6</volume>: <fpage>1037</fpage>–<lpage>1047</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.2217/fmb.11.88" xlink:type="simple">10.2217/fmb.11.88</ext-link></comment> <object-id pub-id-type="pmid">21958143</object-id></mixed-citation></ref>
<ref id="pntd.0004903.ref006"><label>6</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Delespaux</surname> <given-names>V</given-names></name>, <name name-style="western"><surname>Geysen</surname> <given-names>D</given-names></name>, <name name-style="western"><surname>Van den Bossche</surname> <given-names>P</given-names></name>, <name name-style="western"><surname>Geerts</surname> <given-names>S</given-names></name>. <article-title>Molecular tools for the rapid detection of drug resistance in animal trypanosomes</article-title>. <source>Trends in Parasitology</source>. Elsevier; <year>2008</year>;<volume>24</volume>: <fpage>236</fpage>–<lpage>242</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.pt.2008.02.006" xlink:type="simple">10.1016/j.pt.2008.02.006</ext-link></comment> <object-id pub-id-type="pmid">18420457</object-id></mixed-citation></ref>
<ref id="pntd.0004903.ref007"><label>7</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Simarro</surname> <given-names>PP</given-names></name>, <name name-style="western"><surname>Franco</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Diarra</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Postigo</surname> <given-names>JAR</given-names></name>, <name name-style="western"><surname>Jannin</surname> <given-names>J</given-names></name>. <article-title>Update on field use of the available drugs for the chemotherapy of human African trypanosomiasis</article-title>. <source>Parasitology</source>. Cambridge University Press; <year>2012</year>;<volume>139</volume>: <fpage>842</fpage>–<lpage>846</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1017/S0031182012000169" xlink:type="simple">10.1017/S0031182012000169</ext-link></comment> <object-id pub-id-type="pmid">22309684</object-id></mixed-citation></ref>
<ref id="pntd.0004903.ref008"><label>8</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Priotto</surname> <given-names>G</given-names></name>, <name name-style="western"><surname>Kasparian</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Mutombo</surname> <given-names>W</given-names></name>, <name name-style="western"><surname>Ngouama</surname> <given-names>D</given-names></name>, <name name-style="western"><surname>Ghorashian</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Arnold</surname> <given-names>U</given-names></name>, <etal>et al</etal>. <article-title>Nifurtimox-eflornithine combination therapy for second-stage African Trypanosoma brucei gambiense trypanosomiasis: a multicentre, randomised, phase III, non-inferiority trial</article-title>. <source>Lancet</source>. Elsevier; <year>2009</year>;<volume>374</volume>: <fpage>56</fpage>–<lpage>64</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/S0140-6736(09)61117-X" xlink:type="simple">10.1016/S0140-6736(09)61117-X</ext-link></comment> <object-id pub-id-type="pmid">19559476</object-id></mixed-citation></ref>
<ref id="pntd.0004903.ref009"><label>9</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Stich</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Ponte-Sucre</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Holzgrabe</surname> <given-names>U</given-names></name>. <article-title>Do we need new drugs against human African trypanosomiasis?</article-title> <source>Lancet Infect Dis</source>. Elsevier; <year>2013</year>;<volume>13</volume>: <fpage>733</fpage>–<lpage>734</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/S1473-3099(13)70191-9" xlink:type="simple">10.1016/S1473-3099(13)70191-9</ext-link></comment> <object-id pub-id-type="pmid">23969207</object-id></mixed-citation></ref>
<ref id="pntd.0004903.ref010"><label>10</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Nare</surname> <given-names>B</given-names></name>, <name name-style="western"><surname>Wring</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Bacchi</surname> <given-names>C</given-names></name>, <name name-style="western"><surname>Beaudet</surname> <given-names>B</given-names></name>, <name name-style="western"><surname>Bowling</surname> <given-names>T</given-names></name>, <name name-style="western"><surname>Brun</surname> <given-names>R</given-names></name>, <etal>et al</etal>. <article-title>Discovery of novel orally bioavailable oxaborole 6-carboxamides that demonstrate cure in a murine model of late-stage central nervous system african trypanosomiasis</article-title>. <source>Antimicrob Agents Chemother</source>. American Society for Microbiology; <year>2010</year>;<volume>54</volume>: <fpage>4379</fpage>–<lpage>4388</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1128/AAC.00498-10" xlink:type="simple">10.1128/AAC.00498-10</ext-link></comment> <object-id pub-id-type="pmid">20660666</object-id></mixed-citation></ref>
<ref id="pntd.0004903.ref011"><label>11</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Brun</surname> <given-names>R</given-names></name>, <name name-style="western"><surname>Don</surname> <given-names>R</given-names></name>, <name name-style="western"><surname>Jacobs</surname> <given-names>RT</given-names></name>, <name name-style="western"><surname>Wang</surname> <given-names>MZ</given-names></name>, <name name-style="western"><surname>Barrett</surname> <given-names>MP</given-names></name>. <article-title>Development of novel drugs for human African trypanosomiasis</article-title>. <source>Future Microbiol</source>. Future Medicine Ltd London, UK; <year>2011</year>;<volume>6</volume>: <fpage>677</fpage>–<lpage>691</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.2217/fmb.11.44" xlink:type="simple">10.2217/fmb.11.44</ext-link></comment> <object-id pub-id-type="pmid">21707314</object-id></mixed-citation></ref>
<ref id="pntd.0004903.ref012"><label>12</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Barry</surname> <given-names>JD</given-names></name>, <name name-style="western"><surname>McCulloch</surname> <given-names>R</given-names></name>. <article-title>Antigenic variation in trypanosomes: enhanced phenotypic variation in a eukaryotic parasite</article-title>. <source>Adv Parasitol</source>. <year>2001</year>;<volume>49</volume>: <fpage>1</fpage>–<lpage>70</lpage>. <object-id pub-id-type="pmid">11461029</object-id></mixed-citation></ref>
<ref id="pntd.0004903.ref013"><label>13</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Mugnier</surname> <given-names>MR</given-names></name>, <name name-style="western"><surname>Cross</surname> <given-names>GAM</given-names></name>, <name name-style="western"><surname>Papavasiliou</surname> <given-names>FN</given-names></name>. <article-title>The in vivo dynamics of antigenic variation in Trypanosoma brucei</article-title>. <source>Science</source>. American Association for the Advancement of Science; <year>2015</year>;<volume>347</volume>: <fpage>1470</fpage>–<lpage>1473</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1126/science.aaa4502" xlink:type="simple">10.1126/science.aaa4502</ext-link></comment> <object-id pub-id-type="pmid">25814582</object-id></mixed-citation></ref>
<ref id="pntd.0004903.ref014"><label>14</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Thomson</surname> <given-names>R</given-names></name>, <name name-style="western"><surname>Molina-Portela</surname> <given-names>P</given-names></name>, <name name-style="western"><surname>Mott</surname> <given-names>H</given-names></name>, <name name-style="western"><surname>Carrington</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Raper</surname> <given-names>J</given-names></name>. <article-title>Hydrodynamic gene delivery of baboon trypanosome lytic factor eliminates both animal and human-infective African trypanosomes</article-title>. <source>Proc Natl Acad Sci USA</source>. National Acad Sciences; <year>2009</year>;<volume>106</volume>: <fpage>19509</fpage>–<lpage>19514</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1073/pnas.0905669106" xlink:type="simple">10.1073/pnas.0905669106</ext-link></comment> <object-id pub-id-type="pmid">19858474</object-id></mixed-citation></ref>
<ref id="pntd.0004903.ref015"><label>15</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Lukeš</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Raper</surname> <given-names>J</given-names></name>. <article-title>Prophylactic antiparasitic transgenesis for human parasitic disease?</article-title> <source>Mol Ther</source>. Nature Publishing Group; <year>2010</year>;<volume>18</volume>: <fpage>1745</fpage>–<lpage>1747</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1038/mt.2010.193" xlink:type="simple">10.1038/mt.2010.193</ext-link></comment> <object-id pub-id-type="pmid">20885434</object-id></mixed-citation></ref>
<ref id="pntd.0004903.ref016"><label>16</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Hajduk</surname> <given-names>SL</given-names></name>, <name name-style="western"><surname>Hager</surname> <given-names>KM</given-names></name>, <name name-style="western"><surname>Esko</surname> <given-names>JD</given-names></name>. <article-title>Human high density lipoprotein killing of African trypanosomes</article-title>. <source>Annu Rev Microbiol</source>. Annual Reviews 4139 El Camino Way, P.O. Box 10139, Palo Alto, CA 94303–0139, USA; <year>1994</year>;<volume>48</volume>: <fpage>139</fpage>–<lpage>162</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1146/annurev.mi.48.100194.001035" xlink:type="simple">10.1146/annurev.mi.48.100194.001035</ext-link></comment> <object-id pub-id-type="pmid">7826003</object-id></mixed-citation></ref>
<ref id="pntd.0004903.ref017"><label>17</label><mixed-citation publication-type="book" xlink:type="simple"><name name-style="western"><surname>Laveran</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Mesnil</surname> <given-names>F</given-names></name>. <source>Trypanosomes and Trypanosomiases</source>. <publisher-loc>Paris</publisher-loc>: <publisher-name>Masson et Cie</publisher-name>; <year>1912</year>.</mixed-citation></ref>
<ref id="pntd.0004903.ref018"><label>18</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Rifkin</surname> <given-names>MR</given-names></name>. <article-title>Identification of the trypanocidal factor in normal human serum: high density lipoprotein</article-title>. <source>Proc Natl Acad Sci USA</source>. National Academy of Sciences; <year>1978</year>;<volume>75</volume>: <fpage>3450</fpage>–<lpage>3454</lpage>. <object-id pub-id-type="pmid">210461</object-id></mixed-citation></ref>
<ref id="pntd.0004903.ref019"><label>19</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Hajduk</surname> <given-names>SL</given-names></name>, <name name-style="western"><surname>Moore</surname> <given-names>DR</given-names></name>, <name name-style="western"><surname>Vasudevacharya</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Siqueira</surname> <given-names>H</given-names></name>, <name name-style="western"><surname>Torri</surname> <given-names>AF</given-names></name>, <name name-style="western"><surname>Tytler</surname> <given-names>EM</given-names></name>, <etal>et al</etal>. <article-title>Lysis of Trypanosoma brucei by a toxic subspecies of human high density lipoprotein</article-title>. <source>Journal of Biological Chemistry</source>. <year>1989</year>;<volume>264</volume>: <fpage>5210</fpage>–<lpage>5217</lpage>. <object-id pub-id-type="pmid">2494183</object-id></mixed-citation></ref>
<ref id="pntd.0004903.ref020"><label>20</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Raper</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Portela</surname> <given-names>MP</given-names></name>, <name name-style="western"><surname>Lugli</surname> <given-names>E</given-names></name>, <name name-style="western"><surname>Frevert</surname> <given-names>U</given-names></name>, <name name-style="western"><surname>Tomlinson</surname> <given-names>S</given-names></name>. <article-title>Trypanosome lytic factors: novel mediators of human innate immunity</article-title>. <source>Curr Opin Microbiol</source>. <year>2001</year>;<volume>4</volume>: <fpage>402</fpage>–<lpage>408</lpage>. <object-id pub-id-type="pmid">11495802</object-id></mixed-citation></ref>
<ref id="pntd.0004903.ref021"><label>21</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Tomlinson</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Jansen</surname> <given-names>AM</given-names></name>, <name name-style="western"><surname>Koudinov</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Ghiso</surname> <given-names>JA</given-names></name>, <name name-style="western"><surname>Choi-Miura</surname> <given-names>NH</given-names></name>, <name name-style="western"><surname>Rifkin</surname> <given-names>MR</given-names></name>, <etal>et al</etal>. <article-title>High-density-lipoprotein-independent killing of Trypanosoma brucei by human serum</article-title>. <source>Molecular and Biochemical Parasitology</source>. <year>1995</year>;<volume>70</volume>: <fpage>131</fpage>–<lpage>138</lpage>. <object-id pub-id-type="pmid">7637693</object-id></mixed-citation></ref>
<ref id="pntd.0004903.ref022"><label>22</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Vanhollebeke</surname> <given-names>B</given-names></name>, <name name-style="western"><surname>Nielsen</surname> <given-names>MJ</given-names></name>, <name name-style="western"><surname>Watanabe</surname> <given-names>Y</given-names></name>, <name name-style="western"><surname>Truc</surname> <given-names>P</given-names></name>, <name name-style="western"><surname>Vanhamme</surname> <given-names>L</given-names></name>, <name name-style="western"><surname>Nakajima</surname> <given-names>K</given-names></name>, <etal>et al</etal>. <article-title>Distinct roles of haptoglobin-related protein and apolipoprotein L-I in trypanolysis by human serum</article-title>. <source>Proc Natl Acad Sci USA</source>. National Acad Sciences; <year>2007</year>;<volume>104</volume>: <fpage>4118</fpage>–<lpage>4123</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1073/pnas.0609902104" xlink:type="simple">10.1073/pnas.0609902104</ext-link></comment> <object-id pub-id-type="pmid">17360487</object-id></mixed-citation></ref>
<ref id="pntd.0004903.ref023"><label>23</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Widener</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Nielsen</surname> <given-names>MJ</given-names></name>, <name name-style="western"><surname>Shiflett</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Moestrup</surname> <given-names>SK</given-names></name>, <name name-style="western"><surname>Hajduk</surname> <given-names>S</given-names></name>. <article-title>Hemoglobin is a co-factor of human trypanosome lytic factor</article-title>. <source>PLOS Pathog</source>. Public Library of Science; <year>2007</year>;<volume>3</volume>: <fpage>1250</fpage>–<lpage>1261</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1371/journal.ppat.0030129" xlink:type="simple">10.1371/journal.ppat.0030129</ext-link></comment> <object-id pub-id-type="pmid">17845074</object-id></mixed-citation></ref>
<ref id="pntd.0004903.ref024"><label>24</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Drain</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Bishop</surname> <given-names>JR</given-names></name>, <name name-style="western"><surname>Hajduk</surname> <given-names>SL</given-names></name>. <article-title>Haptoglobin-related protein mediates trypanosome lytic factor binding to trypanosomes</article-title>. <source>Journal of Biological Chemistry</source>. American Society for Biochemistry and Molecular Biology; <year>2001</year>;<volume>276</volume>: <fpage>30254</fpage>–<lpage>30260</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1074/jbc.M010198200" xlink:type="simple">10.1074/jbc.M010198200</ext-link></comment> <object-id pub-id-type="pmid">11352898</object-id></mixed-citation></ref>
<ref id="pntd.0004903.ref025"><label>25</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Hager</surname> <given-names>KM</given-names></name>, <name name-style="western"><surname>Pierce</surname> <given-names>MA</given-names></name>, <name name-style="western"><surname>Moore</surname> <given-names>DR</given-names></name>, <name name-style="western"><surname>Tytler</surname> <given-names>EM</given-names></name>, <name name-style="western"><surname>Esko</surname> <given-names>JD</given-names></name>, <name name-style="western"><surname>Hajduk</surname> <given-names>SL</given-names></name>. <article-title>Endocytosis of a cytotoxic human high density lipoprotein results in disruption of acidic intracellular vesicles and subsequent killing of African trypanosomes</article-title>. <source>J Cell Biol</source>. The Rockefeller University Press; <year>1994</year>;<volume>126</volume>: <fpage>155</fpage>–<lpage>167</lpage>. <object-id pub-id-type="pmid">8027174</object-id></mixed-citation></ref>
<ref id="pntd.0004903.ref026"><label>26</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Raper</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Nussenzweig</surname> <given-names>V</given-names></name>, <name name-style="western"><surname>Tomlinson</surname> <given-names>S</given-names></name>. <article-title>The main lytic factor of Trypanosoma brucei brucei in normal human serum is not high density lipoprotein</article-title>. <source>J Exp Med</source>. The Rockefeller University Press; <year>1996</year>;<volume>183</volume>: <fpage>1023</fpage>–<lpage>1029</lpage>. <object-id pub-id-type="pmid">8642243</object-id></mixed-citation></ref>
<ref id="pntd.0004903.ref027"><label>27</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Vanhamme</surname> <given-names>L</given-names></name>, <name name-style="western"><surname>Paturiaux-Hanocq</surname> <given-names>F</given-names></name>, <name name-style="western"><surname>Poelvoorde</surname> <given-names>P</given-names></name>, <name name-style="western"><surname>Nolan</surname> <given-names>DP</given-names></name>, <name name-style="western"><surname>Lins</surname> <given-names>L</given-names></name>, <name name-style="western"><surname>Van Den Abbeele</surname> <given-names>J</given-names></name>, <etal>et al</etal>. <article-title>Apolipoprotein L-I is the trypanosome lytic factor of human serum</article-title>. <source>Nature</source>. Nature Publishing Group; <year>2003</year>;<volume>422</volume>: <fpage>83</fpage>–<lpage>87</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1038/nature01461" xlink:type="simple">10.1038/nature01461</ext-link></comment> <object-id pub-id-type="pmid">12621437</object-id></mixed-citation></ref>
<ref id="pntd.0004903.ref028"><label>28</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Molina-Portela</surname> <given-names>MP</given-names></name>, <name name-style="western"><surname>Samanovic</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Raper</surname> <given-names>J</given-names></name>. <article-title>Distinct roles of apolipoprotein components within the trypanosome lytic factor complex revealed in a novel transgenic mouse model</article-title>. <source>J Exp Med</source>. <year>2008</year>;<volume>205</volume>: <fpage>1721</fpage>–<lpage>1728</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1084/jem.20071463" xlink:type="simple">10.1084/jem.20071463</ext-link></comment> <object-id pub-id-type="pmid">18606856</object-id></mixed-citation></ref>
<ref id="pntd.0004903.ref029"><label>29</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Vanhollebeke</surname> <given-names>B</given-names></name>, <name name-style="western"><surname>Pays</surname> <given-names>E</given-names></name>. <article-title>The function of apolipoproteins L</article-title>. <source>Cell Mol Life Sci</source>. <year>2006</year>;<volume>63</volume>: <fpage>1937</fpage>–<lpage>1944</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1007/s00018-006-6091-x" xlink:type="simple">10.1007/s00018-006-6091-x</ext-link></comment> <object-id pub-id-type="pmid">16847577</object-id></mixed-citation></ref>
<ref id="pntd.0004903.ref030"><label>30</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Harrington</surname> <given-names>JM</given-names></name>, <name name-style="western"><surname>Howell</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Hajduk</surname> <given-names>SL</given-names></name>. <article-title>Membrane permeabilization by trypanosome lytic factor, a cytolytic human high density lipoprotein</article-title>. <source>Journal of Biological Chemistry</source>. American Society for Biochemistry and Molecular Biology; <year>2009</year>;<volume>284</volume>: <fpage>13505</fpage>–<lpage>13512</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1074/jbc.M900151200" xlink:type="simple">10.1074/jbc.M900151200</ext-link></comment> <object-id pub-id-type="pmid">19324878</object-id></mixed-citation></ref>
<ref id="pntd.0004903.ref031"><label>31</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Molina-Portela</surname> <given-names>MDP</given-names></name>, <name name-style="western"><surname>Lugli</surname> <given-names>EB</given-names></name>, <name name-style="western"><surname>Recio-Pinto</surname> <given-names>E</given-names></name>, <name name-style="western"><surname>Raper</surname> <given-names>J</given-names></name>. <article-title>Trypanosome lytic factor, a subclass of high-density lipoprotein, forms cation-selective pores in membranes</article-title>. <source>Molecular and Biochemical Parasitology</source>. <year>2005</year>;<volume>144</volume>: <fpage>218</fpage>–<lpage>226</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.molbiopara.2005.08.018" xlink:type="simple">10.1016/j.molbiopara.2005.08.018</ext-link></comment> <object-id pub-id-type="pmid">16202458</object-id></mixed-citation></ref>
<ref id="pntd.0004903.ref032"><label>32</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Pérez-Morga</surname> <given-names>D</given-names></name>, <name name-style="western"><surname>Vanhollebeke</surname> <given-names>B</given-names></name>, <name name-style="western"><surname>Paturiaux-Hanocq</surname> <given-names>F</given-names></name>, <name name-style="western"><surname>Nolan</surname> <given-names>DP</given-names></name>, <name name-style="western"><surname>Lins</surname> <given-names>L</given-names></name>, <name name-style="western"><surname>Homblé</surname> <given-names>F</given-names></name>, <etal>et al</etal>. <article-title>Apolipoprotein L-I promotes trypanosome lysis by forming pores in lysosomal membranes</article-title>. <source>Science</source>. American Association for the Advancement of Science; <year>2005</year>;<volume>309</volume>: <fpage>469</fpage>–<lpage>472</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1126/science.1114566" xlink:type="simple">10.1126/science.1114566</ext-link></comment> <object-id pub-id-type="pmid">16020735</object-id></mixed-citation></ref>
<ref id="pntd.0004903.ref033"><label>33</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Vanwalleghem</surname> <given-names>G</given-names></name>, <name name-style="western"><surname>Fontaine</surname> <given-names>F</given-names></name>, <name name-style="western"><surname>Lecordier</surname> <given-names>L</given-names></name>, <name name-style="western"><surname>Tebabi</surname> <given-names>P</given-names></name>, <name name-style="western"><surname>Klewe</surname> <given-names>K</given-names></name>, <name name-style="western"><surname>Nolan</surname> <given-names>DP</given-names></name>, <etal>et al</etal>. <article-title>Coupling of lysosomal and mitochondrial membrane permeabilization in trypanolysis by APOL1</article-title>. <source>Nat Commun</source>. Nature Publishing Group; <year>2015</year>;<volume>6</volume>: <fpage>8078</fpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1038/ncomms9078" xlink:type="simple">10.1038/ncomms9078</ext-link></comment> <object-id pub-id-type="pmid">26307671</object-id></mixed-citation></ref>
<ref id="pntd.0004903.ref034"><label>34</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Thomson</surname> <given-names>R</given-names></name>, <name name-style="western"><surname>Finkelstein</surname> <given-names>A</given-names></name>. <article-title>Human trypanolytic factor APOL1 forms pH-gated cation-selective channels in planar lipid bilayers: relevance to trypanosome lysis</article-title>. <source>Proc Natl Acad Sci USA</source>. National Acad Sciences; <year>2015</year>;<volume>112</volume>: <fpage>2894</fpage>–<lpage>2899</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1073/pnas.1421953112" xlink:type="simple">10.1073/pnas.1421953112</ext-link></comment> <object-id pub-id-type="pmid">25730870</object-id></mixed-citation></ref>
<ref id="pntd.0004903.ref035"><label>35</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Van Xong</surname> <given-names>H</given-names></name>, <name name-style="western"><surname>Vanhamme</surname> <given-names>L</given-names></name>, <name name-style="western"><surname>Chamekh</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Chimfwembe</surname> <given-names>CE</given-names></name>, <name name-style="western"><surname>Van Den Abbeele</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Pays</surname> <given-names>A</given-names></name>, <etal>et al</etal>. <article-title>A VSG Expression Site–Associated Gene Confers Resistance to Human Serum in Trypanosoma rhodesiense</article-title>. <source>Cell</source>. <year>1998</year>;<volume>95</volume>: <fpage>839</fpage>–<lpage>846</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/S0092-8674(00)81706-7" xlink:type="simple">10.1016/S0092-8674(00)81706-7</ext-link></comment> <object-id pub-id-type="pmid">9865701</object-id></mixed-citation></ref>
<ref id="pntd.0004903.ref036"><label>36</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>De Greef</surname> <given-names>C</given-names></name>, <name name-style="western"><surname>Imberechts</surname> <given-names>H</given-names></name>, <name name-style="western"><surname>Matthyssens</surname> <given-names>G</given-names></name>, <name name-style="western"><surname>Van Meirvenne</surname> <given-names>N</given-names></name>, <name name-style="western"><surname>Hamers</surname> <given-names>R</given-names></name>. <article-title>A gene expressed only in serum-resistant variants of Trypanosoma brucei rhodesiense</article-title>. <source>Molecular and Biochemical Parasitology</source>. <year>1989</year>;<volume>36</volume>: <fpage>169</fpage>–<lpage>176</lpage>. <object-id pub-id-type="pmid">2528066</object-id></mixed-citation></ref>
<ref id="pntd.0004903.ref037"><label>37</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Lecordier</surname> <given-names>L</given-names></name>, <name name-style="western"><surname>Vanhollebeke</surname> <given-names>B</given-names></name>, <name name-style="western"><surname>Poelvoorde</surname> <given-names>P</given-names></name>, <name name-style="western"><surname>Tebabi</surname> <given-names>P</given-names></name>, <name name-style="western"><surname>Paturiaux-Hanocq</surname> <given-names>F</given-names></name>, <name name-style="western"><surname>Andris</surname> <given-names>F</given-names></name>, <etal>et al</etal>. <article-title>C-terminal mutants of apolipoprotein L-I efficiently kill both Trypanosoma brucei brucei and Trypanosoma brucei rhodesiense</article-title>. <name name-style="western"><surname>Mansfield</surname> <given-names>JM</given-names></name>, editor. <source>PLOS Pathog</source>. Public Library of Science; <year>2009</year>;<volume>5</volume>: <fpage>e1000685</fpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1371/journal.ppat.1000685" xlink:type="simple">10.1371/journal.ppat.1000685</ext-link></comment> <object-id pub-id-type="pmid">19997494</object-id></mixed-citation></ref>
<ref id="pntd.0004903.ref038"><label>38</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Stephens</surname> <given-names>NA</given-names></name>, <name name-style="western"><surname>Hajduk</surname> <given-names>SL</given-names></name>. <article-title>Endosomal localization of the serum resistance-associated protein in African trypanosomes confers human infectivity</article-title>. <source>Eukaryotic Cell</source>. <year>2011</year>;<volume>10</volume>: <fpage>1023</fpage>–<lpage>1033</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1128/EC.05112-11" xlink:type="simple">10.1128/EC.05112-11</ext-link></comment> <object-id pub-id-type="pmid">21705681</object-id></mixed-citation></ref>
<ref id="pntd.0004903.ref039"><label>39</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Bart</surname> <given-names>J-M</given-names></name>, <name name-style="western"><surname>Cordon-Obras</surname> <given-names>C</given-names></name>, <name name-style="western"><surname>Vidal</surname> <given-names>I</given-names></name>, <name name-style="western"><surname>Reed</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Perez-Pastrana</surname> <given-names>E</given-names></name>, <name name-style="western"><surname>Cuevas</surname> <given-names>L</given-names></name>, <etal>et al</etal>. <article-title>Localization of serum resistance-associated protein in Trypanosoma brucei rhodesiense and transgenic Trypanosoma brucei brucei</article-title>. <source>Cell Microbiol</source>. <year>2015</year>;: n/a–n/a. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1111/cmi.12454" xlink:type="simple">10.1111/cmi.12454</ext-link></comment></mixed-citation></ref>
<ref id="pntd.0004903.ref040"><label>40</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Pays</surname> <given-names>E</given-names></name>, <name name-style="western"><surname>Vanhollebeke</surname> <given-names>B</given-names></name>, <name name-style="western"><surname>Uzureau</surname> <given-names>P</given-names></name>, <name name-style="western"><surname>Lecordier</surname> <given-names>L</given-names></name>, <name name-style="western"><surname>Pérez-Morga</surname> <given-names>D</given-names></name>. <article-title>The molecular arms race between African trypanosomes and humans</article-title>. <source>Nature Reviews Microbiology</source>. Nature Publishing Group; <year>2014</year>;<volume>12</volume>: <fpage>575</fpage>–<lpage>584</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1038/nrmicro3298" xlink:type="simple">10.1038/nrmicro3298</ext-link></comment> <object-id pub-id-type="pmid">24975321</object-id></mixed-citation></ref>
<ref id="pntd.0004903.ref041"><label>41</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Gibson</surname> <given-names>WC</given-names></name>, <name name-style="western"><surname>de C Marshall</surname> <given-names>TF</given-names></name>, <name name-style="western"><surname>Godfrey</surname> <given-names>DG</given-names></name>. <article-title>Numerical analysis of enzyme polymorphism: a new approach to the epidemiology and taxonomy of trypanosomes of the subgenus Trypanozoon</article-title>. <source>Adv Parasitol</source>. <year>1980</year>;<volume>18</volume>: <fpage>175</fpage>–<lpage>246</lpage>. <object-id pub-id-type="pmid">7001872</object-id></mixed-citation></ref>
<ref id="pntd.0004903.ref042"><label>42</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Mehlitz</surname> <given-names>D</given-names></name>, <name name-style="western"><surname>Zillmann</surname> <given-names>U</given-names></name>, <name name-style="western"><surname>Scott</surname> <given-names>CM</given-names></name>, <name name-style="western"><surname>Godfrey</surname> <given-names>DG</given-names></name>. <article-title>Epidemiological studies on the animal reservoir of Gambiense sleeping sickness. Part III. Characterization of trypanozoon stocks by isoenzymes and sensitivity to human serum</article-title>. <source>Tropenmed Parasitol</source>. <year>1982</year>;<volume>33</volume>: <fpage>113</fpage>–<lpage>118</lpage>. <object-id pub-id-type="pmid">6287687</object-id></mixed-citation></ref>
<ref id="pntd.0004903.ref043"><label>43</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Tait</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Babiker</surname> <given-names>EA</given-names></name>, <name name-style="western"><surname>Le Ray</surname> <given-names>D</given-names></name>. <article-title>Enzyme variation in Trypanosoma brucei spp. I. Evidence for the sub-speciation of Trypanosoma brucei gambiense</article-title>. <source>Parasitology</source>. <year>1984</year>;<volume>89</volume> (<issue>Pt 2</issue>): <fpage>311</fpage>–<lpage>326</lpage>. <object-id pub-id-type="pmid">6504561</object-id></mixed-citation></ref>
<ref id="pntd.0004903.ref044"><label>44</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Gibson</surname> <given-names>WC</given-names></name>. <article-title>Will the real Trypanosoma b. gambiense please stand up</article-title>. <source>Parasitol Today (Regul Ed)</source>. <year>1986</year>;<volume>2</volume>: <fpage>255</fpage>–<lpage>257</lpage>.</mixed-citation></ref>
<ref id="pntd.0004903.ref045"><label>45</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Weir</surname> <given-names>W</given-names></name>, <name name-style="western"><surname>Capewell</surname> <given-names>P</given-names></name>, <name name-style="western"><surname>Foth</surname> <given-names>B</given-names></name>, <name name-style="western"><surname>Clucas</surname> <given-names>C</given-names></name>, <name name-style="western"><surname>Pountain</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Steketee</surname> <given-names>P</given-names></name>, <etal>et al</etal>. <article-title>Population genomics reveals the origin and asexual evolution of human infective trypanosomes</article-title>. <source>Elife</source>. eLife Sciences Publications Limited; <year>2016</year>;<volume>5</volume>: pdb.ip71. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.7554/eLife.11473" xlink:type="simple">10.7554/eLife.11473</ext-link></comment></mixed-citation></ref>
<ref id="pntd.0004903.ref046"><label>46</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Simarro</surname> <given-names>PP</given-names></name>, <name name-style="western"><surname>Cecchi</surname> <given-names>G</given-names></name>, <name name-style="western"><surname>Paone</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Franco</surname> <given-names>JR</given-names></name>, <name name-style="western"><surname>Diarra</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Ruiz</surname> <given-names>JA</given-names></name>, <etal>et al</etal>. <article-title>The Atlas of human African trypanosomiasis: a contribution to global mapping of neglected tropical diseases</article-title>. <source>Int J Health Geogr</source>. BioMed Central Ltd; <year>2010</year>;<volume>9</volume>: <fpage>57</fpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1186/1476-072X-9-57" xlink:type="simple">10.1186/1476-072X-9-57</ext-link></comment> <object-id pub-id-type="pmid">21040555</object-id></mixed-citation></ref>
<ref id="pntd.0004903.ref047"><label>47</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Zillmann</surname> <given-names>U</given-names></name>, <name name-style="western"><surname>Mehlitz</surname> <given-names>D</given-names></name>, <name name-style="western"><surname>Sachs</surname> <given-names>R</given-names></name>. <article-title>Identity of Trypanozoon stocks isolated from man and a domestic dog in Liberia</article-title>. <source>Tropenmed Parasitol</source>. <year>1984</year>;<volume>35</volume>: <fpage>105</fpage>–<lpage>108</lpage>. <object-id pub-id-type="pmid">6464184</object-id></mixed-citation></ref>
<ref id="pntd.0004903.ref048"><label>48</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Capewell</surname> <given-names>P</given-names></name>, <name name-style="western"><surname>Veitch</surname> <given-names>NJ</given-names></name>, <name name-style="western"><surname>Turner</surname> <given-names>CMR</given-names></name>, <name name-style="western"><surname>Raper</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Berriman</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Hajduk</surname> <given-names>SL</given-names></name>, <etal>et al</etal>. <article-title>Differences between Trypanosoma brucei gambiense groups 1 and 2 in their resistance to killing by trypanolytic factor 1</article-title>. <name name-style="western"><surname>Büscher</surname> <given-names>P</given-names></name>, editor. <source>PLOS Negl Trop Dis</source>. Public Library of Science; <year>2011</year>;<volume>5</volume>: <fpage>e1287</fpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1371/journal.pntd.0001287" xlink:type="simple">10.1371/journal.pntd.0001287</ext-link></comment> <object-id pub-id-type="pmid">21909441</object-id></mixed-citation></ref>
<ref id="pntd.0004903.ref049"><label>49</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Kieft</surname> <given-names>R</given-names></name>, <name name-style="western"><surname>Capewell</surname> <given-names>P</given-names></name>, <name name-style="western"><surname>Turner</surname> <given-names>CMR</given-names></name>, <name name-style="western"><surname>Veitch</surname> <given-names>NJ</given-names></name>, <name name-style="western"><surname>MacLeod</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Hajduk</surname> <given-names>S</given-names></name>. <article-title>Mechanism of Trypanosoma brucei gambiense (group 1) resistance to human trypanosome lytic factor</article-title>. <source>Proc Natl Acad Sci USA</source>. National Acad Sciences; <year>2010</year>;<volume>107</volume>: <fpage>16137</fpage>–<lpage>16141</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1073/pnas.1007074107" xlink:type="simple">10.1073/pnas.1007074107</ext-link></comment> <object-id pub-id-type="pmid">20805508</object-id></mixed-citation></ref>
<ref id="pntd.0004903.ref050"><label>50</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>DeJesus</surname> <given-names>E</given-names></name>, <name name-style="western"><surname>Kieft</surname> <given-names>R</given-names></name>, <name name-style="western"><surname>Albright</surname> <given-names>B</given-names></name>, <name name-style="western"><surname>Stephens</surname> <given-names>NA</given-names></name>, <name name-style="western"><surname>Hajduk</surname> <given-names>SL</given-names></name>. <article-title>A single amino acid substitution in the group 1 Trypanosoma brucei gambiense haptoglobin-hemoglobin receptor abolishes TLF-1 binding</article-title>. <name name-style="western"><surname>Hill</surname> <given-names>KL</given-names></name>, editor. <source>PLOS Pathog</source>. Public Library of Science; <year>2013</year>;<volume>9</volume>: <fpage>e1003317</fpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1371/journal.ppat.1003317" xlink:type="simple">10.1371/journal.ppat.1003317</ext-link></comment> <object-id pub-id-type="pmid">23637606</object-id></mixed-citation></ref>
<ref id="pntd.0004903.ref051"><label>51</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Capewell</surname> <given-names>P</given-names></name>, <name name-style="western"><surname>Clucas</surname> <given-names>C</given-names></name>, <name name-style="western"><surname>DeJesus</surname> <given-names>E</given-names></name>, <name name-style="western"><surname>Kieft</surname> <given-names>R</given-names></name>, <name name-style="western"><surname>Hajduk</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Veitch</surname> <given-names>N</given-names></name>, <etal>et al</etal>. <article-title>The TgsGP Gene Is Essential for Resistance to Human Serum in Trypanosoma brucei gambiense</article-title>. <name name-style="western"><surname>Alsford</surname> <given-names>S</given-names></name>, editor. <source>PLOS Pathog</source>. Public Library of Science; <year>2013</year>;<volume>9</volume>: <fpage>e1003686</fpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1371/journal.ppat.1003686" xlink:type="simple">10.1371/journal.ppat.1003686</ext-link></comment> <object-id pub-id-type="pmid">24098129</object-id></mixed-citation></ref>
<ref id="pntd.0004903.ref052"><label>52</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Uzureau</surname> <given-names>P</given-names></name>, <name name-style="western"><surname>Uzureau</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Lecordier</surname> <given-names>L</given-names></name>, <name name-style="western"><surname>Fontaine</surname> <given-names>F</given-names></name>, <name name-style="western"><surname>Tebabi</surname> <given-names>P</given-names></name>, <name name-style="western"><surname>Homblé</surname> <given-names>F</given-names></name>, <etal>et al</etal>. <article-title>Mechanism of Trypanosoma brucei gambiense resistance to human serum</article-title>. <source>Nature</source>. Nature Publishing Group; <year>2013</year>;<volume>501</volume>: <fpage>430</fpage>–<lpage>434</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1038/nature12516" xlink:type="simple">10.1038/nature12516</ext-link></comment> <object-id pub-id-type="pmid">23965626</object-id></mixed-citation></ref>
<ref id="pntd.0004903.ref053"><label>53</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Alsford</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Currier</surname> <given-names>RB</given-names></name>, <name name-style="western"><surname>Guerra-Assunção</surname> <given-names>JA</given-names></name>, <name name-style="western"><surname>Clark</surname> <given-names>TG</given-names></name>, <name name-style="western"><surname>Horn</surname> <given-names>D</given-names></name>. <article-title>Cathepsin-L can resist lysis by human serum in Trypanosoma brucei brucei</article-title>. <name name-style="western"><surname>Beverley</surname> <given-names>SM</given-names></name>, editor. <source>PLOS Pathog</source>. Public Library of Science; <year>2014</year>;<volume>10</volume>: <fpage>e1004130</fpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1371/journal.ppat.1004130" xlink:type="simple">10.1371/journal.ppat.1004130</ext-link></comment> <object-id pub-id-type="pmid">24830321</object-id></mixed-citation></ref>
<ref id="pntd.0004903.ref054"><label>54</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Balmer</surname> <given-names>O</given-names></name>, <name name-style="western"><surname>Beadell</surname> <given-names>JS</given-names></name>, <name name-style="western"><surname>Gibson</surname> <given-names>W</given-names></name>, <name name-style="western"><surname>Caccone</surname> <given-names>A</given-names></name>. <article-title>Phylogeography and taxonomy of Trypanosoma brucei</article-title>. <name name-style="western"><surname>Solano</surname> <given-names>P</given-names></name>, editor. <source>PLoS Negl Trop Dis</source>. <year>2011</year>;<volume>5</volume>: <fpage>e961</fpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1371/journal.pntd.0000961" xlink:type="simple">10.1371/journal.pntd.0000961</ext-link></comment> <object-id pub-id-type="pmid">21347445</object-id></mixed-citation></ref>
<ref id="pntd.0004903.ref055"><label>55</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Radwanska</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Chamekh</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Vanhamme</surname> <given-names>L</given-names></name>, <name name-style="western"><surname>Claes</surname> <given-names>F</given-names></name>, <name name-style="western"><surname>Magez</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Magnus</surname> <given-names>E</given-names></name>, <etal>et al</etal>. <article-title>The serum resistance-associated gene as a diagnostic tool for the detection of Trypanosoma brucei rhodesiense</article-title>. <source>Am J Trop Med Hyg</source>. <year>2002</year>;<volume>67</volume>: <fpage>684</fpage>–<lpage>690</lpage>. <object-id pub-id-type="pmid">12518862</object-id></mixed-citation></ref>
<ref id="pntd.0004903.ref056"><label>56</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Gibson</surname> <given-names>W</given-names></name>, <name name-style="western"><surname>Nemetschke</surname> <given-names>L</given-names></name>, <name name-style="western"><surname>Ndung'u</surname> <given-names>J</given-names></name>. <article-title>Conserved sequence of the TgsGP gene in Group 1 Trypanosoma brucei gambiense</article-title>. <source>Infect Genet Evol</source>. <year>2010</year>;<volume>10</volume>: <fpage>453</fpage>–<lpage>458</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.meegid.2010.03.005" xlink:type="simple">10.1016/j.meegid.2010.03.005</ext-link></comment> <object-id pub-id-type="pmid">20302972</object-id></mixed-citation></ref>
<ref id="pntd.0004903.ref057"><label>57</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Radwanska</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Claes</surname> <given-names>F</given-names></name>, <name name-style="western"><surname>Magez</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Magnus</surname> <given-names>E</given-names></name>, <name name-style="western"><surname>Pérez-Morga</surname> <given-names>D</given-names></name>, <name name-style="western"><surname>Pays</surname> <given-names>E</given-names></name>, <etal>et al</etal>. <article-title>Novel primer sequences for polymerase chain reaction-based detection of Trypanosoma brucei gambiense</article-title>. <source>Am J Trop Med Hyg</source>. <year>2002</year>;<volume>67</volume>: <fpage>289</fpage>–<lpage>295</lpage>. <object-id pub-id-type="pmid">12408669</object-id></mixed-citation></ref>
<ref id="pntd.0004903.ref058"><label>58</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Lugli</surname> <given-names>EB</given-names></name>, <name name-style="western"><surname>Pouliot</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Portela</surname> <given-names>MDPM</given-names></name>, <name name-style="western"><surname>Loomis</surname> <given-names>MR</given-names></name>, <name name-style="western"><surname>Raper</surname> <given-names>J</given-names></name>. <article-title>Characterization of primate trypanosome lytic factors</article-title>. <source>Molecular and Biochemical Parasitology</source>. <year>2004</year>;<volume>138</volume>: <fpage>9</fpage>–<lpage>20</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.molbiopara.2004.07.004" xlink:type="simple">10.1016/j.molbiopara.2004.07.004</ext-link></comment> <object-id pub-id-type="pmid">15500911</object-id></mixed-citation></ref>
<ref id="pntd.0004903.ref059"><label>59</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Poelvoorde</surname> <given-names>P</given-names></name>, <name name-style="western"><surname>Vanhamme</surname> <given-names>L</given-names></name>, <name name-style="western"><surname>Van Den Abbeele</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Switzer</surname> <given-names>WM</given-names></name>, <name name-style="western"><surname>Pays</surname> <given-names>E</given-names></name>. <article-title>Distribution of apolipoprotein L-I and trypanosome lytic activity among primate sera</article-title>. <source>Molecular and Biochemical Parasitology</source>. <year>2004</year>;<volume>134</volume>: <fpage>155</fpage>–<lpage>157</lpage>. <object-id pub-id-type="pmid">14747153</object-id></mixed-citation></ref>
<ref id="pntd.0004903.ref060"><label>60</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Kumar</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Hedges</surname> <given-names>SB</given-names></name>. <article-title>A molecular timescale for vertebrate evolution</article-title>. <source>Nature</source>. Nature Publishing Group; <year>1998</year>;<volume>392</volume>: <fpage>917</fpage>–<lpage>920</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1038/31927" xlink:type="simple">10.1038/31927</ext-link></comment> <object-id pub-id-type="pmid">9582070</object-id></mixed-citation></ref>
<ref id="pntd.0004903.ref061"><label>61</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Seed</surname> <given-names>JR</given-names></name>, <name name-style="western"><surname>Sechelski</surname> <given-names>JB</given-names></name>, <name name-style="western"><surname>Loomis</surname> <given-names>MR</given-names></name>. <article-title>A survey for a trypanocidal factor in primate sera</article-title>. <source>J Protozool</source>. <year>1990</year>;<volume>37</volume>: <fpage>393</fpage>–<lpage>400</lpage>. <object-id pub-id-type="pmid">2120433</object-id></mixed-citation></ref>
<ref id="pntd.0004903.ref062"><label>62</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Thomson</surname> <given-names>R</given-names></name>, <name name-style="western"><surname>Genovese</surname> <given-names>G</given-names></name>, <name name-style="western"><surname>Canon</surname> <given-names>C</given-names></name>, <name name-style="western"><surname>Kovacsics</surname> <given-names>D</given-names></name>, <name name-style="western"><surname>Higgins</surname> <given-names>MK</given-names></name>, <name name-style="western"><surname>Carrington</surname> <given-names>M</given-names></name>, <etal>et al</etal>. <article-title>Evolution of the primate trypanolytic factor APOL1</article-title>. <source>Proc Natl Acad Sci USA</source>. National Acad Sciences; <year>2014</year>;<volume>111</volume>: <fpage>E2130</fpage>–<lpage>9</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1073/pnas.1400699111" xlink:type="simple">10.1073/pnas.1400699111</ext-link></comment> <object-id pub-id-type="pmid">24808134</object-id></mixed-citation></ref>
<ref id="pntd.0004903.ref063"><label>63</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Genovese</surname> <given-names>G</given-names></name>, <name name-style="western"><surname>Friedman</surname> <given-names>DJ</given-names></name>, <name name-style="western"><surname>Ross</surname> <given-names>MD</given-names></name>, <name name-style="western"><surname>Lecordier</surname> <given-names>L</given-names></name>, <name name-style="western"><surname>Uzureau</surname> <given-names>P</given-names></name>, <name name-style="western"><surname>Freedman</surname> <given-names>BI</given-names></name>, <etal>et al</etal>. <article-title>Association of trypanolytic ApoL1 variants with kidney disease in African Americans</article-title>. <source>Science</source>. American Association for the Advancement of Science; <year>2010</year>;<volume>329</volume>: <fpage>841</fpage>–<lpage>845</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1126/science.1193032" xlink:type="simple">10.1126/science.1193032</ext-link></comment> <object-id pub-id-type="pmid">20647424</object-id></mixed-citation></ref>
<ref id="pntd.0004903.ref064"><label>64</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Kageruka</surname> <given-names>P</given-names></name>, <name name-style="western"><surname>Mangus</surname> <given-names>E</given-names></name>, <name name-style="western"><surname>Bajyana Songa</surname> <given-names>E</given-names></name>, <name name-style="western"><surname>Nantulya</surname> <given-names>V</given-names></name>, <name name-style="western"><surname>Jochems</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Hamers</surname> <given-names>R</given-names></name>, <etal>et al</etal>. <article-title>Infectivity of Trypanosoma (Trypanozoon) brucei gambiense for baboons (Papio hamadryas, Papio papio)</article-title>. <source>Ann Soc Belg Med Trop</source>. <year>1991</year>;<volume>71</volume>: <fpage>39</fpage>–<lpage>46</lpage>. <object-id pub-id-type="pmid">2042999</object-id></mixed-citation></ref>
<ref id="pntd.0004903.ref065"><label>65</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Geigy</surname> <given-names>R</given-names></name>, <name name-style="western"><surname>Kauffmann</surname> <given-names>M</given-names></name>. <article-title>Sleeping sickness survey in the Serengeti area (Tanzania) 1971. I. Examination of large mammals for trypanosomes</article-title>. <source>Acta Trop</source>. <year>1973</year>;<volume>30</volume>: <fpage>12</fpage>–<lpage>23</lpage>. <object-id pub-id-type="pmid">4144952</object-id></mixed-citation></ref>
<ref id="pntd.0004903.ref066"><label>66</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Tait</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Barry</surname> <given-names>JD</given-names></name>, <name name-style="western"><surname>Wink</surname> <given-names>R</given-names></name>, <name name-style="western"><surname>Sanderson</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Crowe</surname> <given-names>JS</given-names></name>. <article-title>Enzyme variation in T. brucei ssp. II. Evidence for T. b. rhodesiense being a set of variants of T. b. brucei</article-title>. <source>Parasitology</source>. <year>1985</year>;<volume>90</volume> (<issue>Pt 1</issue>): <fpage>89</fpage>–<lpage>100</lpage>. <object-id pub-id-type="pmid">3856830</object-id></mixed-citation></ref>
<ref id="pntd.0004903.ref067"><label>67</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Felgner</surname> <given-names>P</given-names></name>, <name name-style="western"><surname>Brinkmann</surname> <given-names>U</given-names></name>, <name name-style="western"><surname>Zillmann</surname> <given-names>U</given-names></name>, <name name-style="western"><surname>Mehlitz</surname> <given-names>D</given-names></name>, <name name-style="western"><surname>Abu-Ishira</surname> <given-names>S</given-names></name>. <article-title>Epidemiological studies on the animal reservoir of gambiense sleeping sickness. Part II. Parasitological and immunodiagnostic examination of the human population</article-title>. <source>Tropenmed Parasitol</source>. <year>1981</year>;<volume>32</volume>: <fpage>134</fpage>–<lpage>140</lpage>. <object-id pub-id-type="pmid">6285560</object-id></mixed-citation></ref>
<ref id="pntd.0004903.ref068"><label>68</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>O'Connell</surname> <given-names>KM</given-names></name>, <name name-style="western"><surname>Hutner</surname> <given-names>SH</given-names></name>, <name name-style="western"><surname>Fromentin</surname> <given-names>H</given-names></name>, <name name-style="western"><surname>Frank</surname> <given-names>O</given-names></name>, <name name-style="western"><surname>Baker</surname> <given-names>H</given-names></name>. <article-title>Cryoprotectants for Crithidia fasciculata stored at -20 C, with notes on Trypanosoma gambiense and T. conorhini</article-title>. <source>J Protozool</source>. <year>1968</year>;<volume>15</volume>: <fpage>719</fpage>–<lpage>724</lpage>. <object-id pub-id-type="pmid">5719068</object-id></mixed-citation></ref>
<ref id="pntd.0004903.ref069"><label>69</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Barnes</surname> <given-names>DA</given-names></name>, <name name-style="western"><surname>Mottram</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Selkirk</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Agabian</surname> <given-names>N</given-names></name>. <article-title>Two variant surface glycoprotein genes distinguish between different substrains of Trypanosoma brucei gambiense</article-title>. <source>Molecular and Biochemical Parasitology</source>. <year>1989</year>;<volume>34</volume>: <fpage>135</fpage>–<lpage>146</lpage>. <object-id pub-id-type="pmid">2469013</object-id></mixed-citation></ref>
<ref id="pntd.0004903.ref070"><label>70</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Holzmuller</surname> <given-names>P</given-names></name>, <name name-style="western"><surname>Biron</surname> <given-names>DG</given-names></name>, <name name-style="western"><surname>Courtois</surname> <given-names>P</given-names></name>, <name name-style="western"><surname>Koffi</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Bras-Gonçalves</surname> <given-names>R</given-names></name>, <name name-style="western"><surname>Daulouède</surname> <given-names>S</given-names></name>, <etal>et al</etal>. <article-title>Virulence and pathogenicity patterns of Trypanosoma brucei gambiense field isolates in experimentally infected mouse: differences in host immune response modulation by secretome and proteomics</article-title>. <source>Microbes Infect</source>. <year>2008</year>;<volume>10</volume>: <fpage>79</fpage>–<lpage>86</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.micinf.2007.10.008" xlink:type="simple">10.1016/j.micinf.2007.10.008</ext-link></comment> <object-id pub-id-type="pmid">18068387</object-id></mixed-citation></ref>
<ref id="pntd.0004903.ref071"><label>71</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Hirumi</surname> <given-names>H</given-names></name>, <name name-style="western"><surname>Hirumi</surname> <given-names>K</given-names></name>. <article-title>Continuous cultivation of Trypanosoma brucei blood stream forms in a medium containing a low concentration of serum protein without feeder cell layers</article-title>. <source>J Parasitol</source>. <year>1989</year>;<volume>75</volume>: <fpage>985</fpage>–<lpage>989</lpage>. <object-id pub-id-type="pmid">2614608</object-id></mixed-citation></ref>
<ref id="pntd.0004903.ref072"><label>72</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Turner</surname> <given-names>CMR</given-names></name>, <name name-style="western"><surname>McLellan</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Lindergard</surname> <given-names>LAG</given-names></name>, <name name-style="western"><surname>Bisoni</surname> <given-names>L</given-names></name>, <name name-style="western"><surname>Tait</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>MacLeod</surname> <given-names>A</given-names></name>. <article-title>Human infectivity trait in Trypanosoma brucei: stability, heritability and relationship to sra expression</article-title>. <source>Parasitology</source>. <year>2004</year>;<volume>129</volume>: <fpage>445</fpage>–<lpage>454</lpage>. <object-id pub-id-type="pmid">15521633</object-id></mixed-citation></ref>
<ref id="pntd.0004903.ref073"><label>73</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>MacLeod</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Tweedie</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>McLellan</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Taylor</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Cooper</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Sweeney</surname> <given-names>L</given-names></name>, <etal>et al</etal>. <article-title>Allelic segregation and independent assortment in T. brucei crosses: Proof that the genetic system is Mendelian and involves meiosis</article-title>. <source>Molecular and Biochemical Parasitology</source>. <year>2005</year>;<volume>143</volume>: <fpage>12</fpage>–<lpage>19</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.molbiopara.2005.04.009" xlink:type="simple">10.1016/j.molbiopara.2005.04.009</ext-link></comment> <object-id pub-id-type="pmid">15941603</object-id></mixed-citation></ref>
<ref id="pntd.0004903.ref074"><label>74</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Duchateau</surname> <given-names>PN</given-names></name>, <name name-style="western"><surname>Movsesyan</surname> <given-names>I</given-names></name>, <name name-style="western"><surname>Yamashita</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Sakai</surname> <given-names>N</given-names></name>, <name name-style="western"><surname>Hirano</surname> <given-names>K</given-names></name>, <name name-style="western"><surname>Schoenhaus</surname> <given-names>SA</given-names></name>, <etal>et al</etal>. <article-title>Plasma apolipoprotein L concentrations correlate with plasma triglycerides and cholesterol levels in normolipidemic, hyperlipidemic, and diabetic subjects</article-title>. <source>J Lipid Res</source>. <year>2000</year>;<volume>41</volume>: <fpage>1231</fpage>–<lpage>1236</lpage>. <object-id pub-id-type="pmid">10946010</object-id></mixed-citation></ref>
<ref id="pntd.0004903.ref075"><label>75</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Weckerle</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Snipes</surname> <given-names>JA</given-names></name>, <name name-style="western"><surname>Cheng</surname> <given-names>D</given-names></name>, <name name-style="western"><surname>Gebre</surname> <given-names>AK</given-names></name>, <name name-style="western"><surname>Reisz</surname> <given-names>JA</given-names></name>, <name name-style="western"><surname>Murea</surname> <given-names>M</given-names></name>, <etal>et al</etal>. <article-title>Characterization of circulating APOL1 protein complexes in African Americans</article-title>. <source>J Lipid Res</source>. American Society for Biochemistry and Molecular Biology; <year>2016</year>;<volume>57</volume>: <fpage>120</fpage>–<lpage>130</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1194/jlr.M063453" xlink:type="simple">10.1194/jlr.M063453</ext-link></comment> <object-id pub-id-type="pmid">26586272</object-id></mixed-citation></ref>
<ref id="pntd.0004903.ref076"><label>76</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Bruggeman</surname> <given-names>LA</given-names></name>, <name name-style="western"><surname>O'Toole</surname> <given-names>JF</given-names></name>, <name name-style="western"><surname>Ross</surname> <given-names>MD</given-names></name>, <name name-style="western"><surname>Madhavan</surname> <given-names>SM</given-names></name>, <name name-style="western"><surname>Smurzynski</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Wu</surname> <given-names>K</given-names></name>, <etal>et al</etal>. <article-title>Plasma apolipoprotein L1 levels do not correlate with CKD</article-title>. <source>J Am Soc Nephrol</source>. American Society of Nephrology; <year>2014</year>;<volume>25</volume>: <fpage>634</fpage>–<lpage>644</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1681/ASN.2013070700" xlink:type="simple">10.1681/ASN.2013070700</ext-link></comment> <object-id pub-id-type="pmid">24231663</object-id></mixed-citation></ref>
<ref id="pntd.0004903.ref077"><label>77</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Pays</surname> <given-names>E</given-names></name>, <name name-style="western"><surname>Vanhollebeke</surname> <given-names>B</given-names></name>, <name name-style="western"><surname>Vanhamme</surname> <given-names>L</given-names></name>, <name name-style="western"><surname>Paturiaux-Hanocq</surname> <given-names>F</given-names></name>, <name name-style="western"><surname>Nolan</surname> <given-names>DP</given-names></name>, <name name-style="western"><surname>Pérez-Morga</surname> <given-names>D</given-names></name>. <article-title>The trypanolytic factor of human serum</article-title>. <source>Nature Reviews Microbiology</source>. Nature Publishing Group; <year>2006</year>;<volume>4</volume>: <fpage>477</fpage>–<lpage>486</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1038/nrmicro1428" xlink:type="simple">10.1038/nrmicro1428</ext-link></comment> <object-id pub-id-type="pmid">16710327</object-id></mixed-citation></ref>
<ref id="pntd.0004903.ref078"><label>78</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Vanhollebeke</surname> <given-names>B</given-names></name>, <name name-style="western"><surname>De Muylder</surname> <given-names>G</given-names></name>, <name name-style="western"><surname>Nielsen</surname> <given-names>MJ</given-names></name>, <name name-style="western"><surname>Pays</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Tebabi</surname> <given-names>P</given-names></name>, <name name-style="western"><surname>Dieu</surname> <given-names>M</given-names></name>, <etal>et al</etal>. <article-title>A haptoglobin-hemoglobin receptor conveys innate immunity to Trypanosoma brucei in humans</article-title>. <source>Science</source>. American Association for the Advancement of Science; <year>2008</year>;<volume>320</volume>: <fpage>677</fpage>–<lpage>681</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1126/science.1156296" xlink:type="simple">10.1126/science.1156296</ext-link></comment> <object-id pub-id-type="pmid">18451305</object-id></mixed-citation></ref>
<ref id="pntd.0004903.ref079"><label>79</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Higgins</surname> <given-names>MK</given-names></name>, <name name-style="western"><surname>Tkachenko</surname> <given-names>O</given-names></name>, <name name-style="western"><surname>Brown</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Reed</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Raper</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Carrington</surname> <given-names>M</given-names></name>. <article-title>Structure of the trypanosome haptoglobin-hemoglobin receptor and implications for nutrient uptake and innate immunity</article-title>. <source>Proc Natl Acad Sci USA</source>. National Acad Sciences; <year>2013</year>;<volume>110</volume>: <fpage>1905</fpage>–<lpage>1910</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1073/pnas.1214943110" xlink:type="simple">10.1073/pnas.1214943110</ext-link></comment> <object-id pub-id-type="pmid">23319650</object-id></mixed-citation></ref>
<ref id="pntd.0004903.ref080"><label>80</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Bullard</surname> <given-names>W</given-names></name>, <name name-style="western"><surname>Kieft</surname> <given-names>R</given-names></name>, <name name-style="western"><surname>Capewell</surname> <given-names>P</given-names></name>, <name name-style="western"><surname>Veitch</surname> <given-names>NJ</given-names></name>, <name name-style="western"><surname>MacLeod</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Hajduk</surname> <given-names>SL</given-names></name>. <article-title>Haptoglobin-hemoglobin receptor independent killing of African trypanosomes by human serum and trypanosome lytic factors</article-title>. <source>Virulence</source>. Taylor &amp; Francis; <year>2012</year>;<volume>3</volume>: <fpage>72</fpage>–<lpage>76</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.4161/viru.3.1.18295" xlink:type="simple">10.4161/viru.3.1.18295</ext-link></comment> <object-id pub-id-type="pmid">22286709</object-id></mixed-citation></ref>
<ref id="pntd.0004903.ref081"><label>81</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Green</surname> <given-names>HP</given-names></name>, <name name-style="western"><surname>Del Pilar Molina Portela</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>St Jean</surname> <given-names>EN</given-names></name>, <name name-style="western"><surname>Lugli</surname> <given-names>EB</given-names></name>, <name name-style="western"><surname>Raper</surname> <given-names>J</given-names></name>. <article-title>Evidence for a Trypanosoma brucei lipoprotein scavenger receptor</article-title>. <source>Journal of Biological Chemistry</source>. American Society for Biochemistry and Molecular Biology; <year>2003</year>;<volume>278</volume>: <fpage>422</fpage>–<lpage>427</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1074/jbc.M207215200" xlink:type="simple">10.1074/jbc.M207215200</ext-link></comment> <object-id pub-id-type="pmid">12401813</object-id></mixed-citation></ref>
<ref id="pntd.0004903.ref082"><label>82</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Raper</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Fung</surname> <given-names>R</given-names></name>, <name name-style="western"><surname>Ghiso</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Nussenzweig</surname> <given-names>V</given-names></name>, <name name-style="western"><surname>Tomlinson</surname> <given-names>S</given-names></name>. <article-title>Characterization of a novel trypanosome lytic factor from human serum</article-title>. <source>Infect Immun</source>. American Society for Microbiology; <year>1999</year>;<volume>67</volume>: <fpage>1910</fpage>–<lpage>1916</lpage>. <object-id pub-id-type="pmid">10085035</object-id></mixed-citation></ref>
<ref id="pntd.0004903.ref083"><label>83</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Vanhollebeke</surname> <given-names>B</given-names></name>, <name name-style="western"><surname>Pays</surname> <given-names>E</given-names></name>. <article-title>The trypanolytic factor of human serum: many ways to enter the parasite, a single way to kill</article-title>. <source>Molecular Microbiology</source>. Blackwell Publishing Ltd; <year>2010</year>;<volume>76</volume>: <fpage>806</fpage>–<lpage>814</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1111/j.1365-2958.2010.07156.x" xlink:type="simple">10.1111/j.1365-2958.2010.07156.x</ext-link></comment> <object-id pub-id-type="pmid">20398209</object-id></mixed-citation></ref>
<ref id="pntd.0004903.ref084"><label>84</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Alexander</surname> <given-names>DL</given-names></name>, <name name-style="western"><surname>Schwartz</surname> <given-names>KJ</given-names></name>, <name name-style="western"><surname>Balber</surname> <given-names>AE</given-names></name>, <name name-style="western"><surname>Bangs</surname> <given-names>JD</given-names></name>. <article-title>Developmentally regulated trafficking of the lysosomal membrane protein p67 in Trypanosoma brucei</article-title>. <source>J Cell Sci</source>. <year>2002</year>;<volume>115</volume>: <fpage>3253</fpage>–<lpage>3263</lpage>. <object-id pub-id-type="pmid">12140257</object-id></mixed-citation></ref>
<ref id="pntd.0004903.ref085"><label>85</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Kelley</surname> <given-names>RJ</given-names></name>, <name name-style="western"><surname>Alexander</surname> <given-names>DL</given-names></name>, <name name-style="western"><surname>Cowan</surname> <given-names>C</given-names></name>, <name name-style="western"><surname>Balber</surname> <given-names>AE</given-names></name>, <name name-style="western"><surname>Bangs</surname> <given-names>JD</given-names></name>. <article-title>Molecular cloning of p67, a lysosomal membrane glycoprotein from Trypanosoma brucei</article-title>. <source>Molecular and Biochemical Parasitology</source>. <year>1999</year>;<volume>98</volume>: <fpage>17</fpage>–<lpage>28</lpage>. <object-id pub-id-type="pmid">10029306</object-id></mixed-citation></ref>
<ref id="pntd.0004903.ref086"><label>86</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Marcello</surname> <given-names>L</given-names></name>, <name name-style="western"><surname>Menon</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Ward</surname> <given-names>P</given-names></name>, <name name-style="western"><surname>Wilkes</surname> <given-names>JM</given-names></name>, <name name-style="western"><surname>Jones</surname> <given-names>NG</given-names></name>, <name name-style="western"><surname>Carrington</surname> <given-names>M</given-names></name>, <etal>et al</etal>. <article-title>VSGdb: a database for trypanosome variant surface glycoproteins, a large and diverse family of coiled coil proteins</article-title>. <source>BMC Bioinformatics</source>. BioMed Central; <year>2007</year>;<volume>8</volume>: <fpage>143</fpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1186/1471-2105-8-143" xlink:type="simple">10.1186/1471-2105-8-143</ext-link></comment> <object-id pub-id-type="pmid">17474977</object-id></mixed-citation></ref>
<ref id="pntd.0004903.ref087"><label>87</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Gibson</surname> <given-names>W</given-names></name>, <name name-style="western"><surname>Ferris</surname> <given-names>V</given-names></name>. <article-title>Conservation of the genomic location of the human serum resistance associated gene in Trypanosoma brucei rhodesiense</article-title>. <source>Molecular and Biochemical Parasitology</source>. <year>2003</year>;<volume>130</volume>: <fpage>159</fpage>–<lpage>162</lpage>. <object-id pub-id-type="pmid">12946855</object-id></mixed-citation></ref>
<ref id="pntd.0004903.ref088"><label>88</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Berberof</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Pérez-Morga</surname> <given-names>D</given-names></name>, <name name-style="western"><surname>Pays</surname> <given-names>E</given-names></name>. <article-title>A receptor-like flagellar pocket glycoprotein specific to Trypanosoma brucei gambiense</article-title>. <source>Molecular and Biochemical Parasitology</source>. <year>2001</year>;<volume>113</volume>: <fpage>127</fpage>–<lpage>138</lpage>. <object-id pub-id-type="pmid">11254961</object-id></mixed-citation></ref>
<ref id="pntd.0004903.ref089"><label>89</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Kopp</surname> <given-names>JB</given-names></name>, <name name-style="western"><surname>Nelson</surname> <given-names>GW</given-names></name>, <name name-style="western"><surname>Sampath</surname> <given-names>K</given-names></name>, <name name-style="western"><surname>Johnson</surname> <given-names>RC</given-names></name>, <name name-style="western"><surname>Genovese</surname> <given-names>G</given-names></name>, <name name-style="western"><surname>An</surname> <given-names>P</given-names></name>, <etal>et al</etal>. <article-title>APOL1 genetic variants in focal segmental glomerulosclerosis and HIV-associated nephropathy</article-title>. <source>J Am Soc Nephrol</source>. American Society of Nephrology; <year>2011</year>;<volume>22</volume>: <fpage>2129</fpage>–<lpage>2137</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1681/ASN.2011040388" xlink:type="simple">10.1681/ASN.2011040388</ext-link></comment> <object-id pub-id-type="pmid">21997394</object-id></mixed-citation></ref>
<ref id="pntd.0004903.ref090"><label>90</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Kasembeli</surname> <given-names>AN</given-names></name>, <name name-style="western"><surname>Duarte</surname> <given-names>R</given-names></name>, <name name-style="western"><surname>Ramsay</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Mosiane</surname> <given-names>P</given-names></name>, <name name-style="western"><surname>Dickens</surname> <given-names>C</given-names></name>, <name name-style="western"><surname>Dix-Peek</surname> <given-names>T</given-names></name>, <etal>et al</etal>. <article-title>APOL1 Risk Variants Are Strongly Associated with HIV-Associated Nephropathy in Black South Africans</article-title>. <source>J Am Soc Nephrol</source>. American Society of Nephrology; <year>2015</year>;: ASN.2014050469. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1681/ASN.2014050469" xlink:type="simple">10.1681/ASN.2014050469</ext-link></comment></mixed-citation></ref>
<ref id="pntd.0004903.ref091"><label>91</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Freedman</surname> <given-names>BI</given-names></name>, <name name-style="western"><surname>Langefeld</surname> <given-names>CD</given-names></name>, <name name-style="western"><surname>Andringa</surname> <given-names>KK</given-names></name>, <name name-style="western"><surname>Croker</surname> <given-names>JA</given-names></name>, <name name-style="western"><surname>Williams</surname> <given-names>AH</given-names></name>, <name name-style="western"><surname>Garner</surname> <given-names>NE</given-names></name>, <etal>et al</etal>. <article-title>End-stage renal disease in African Americans with lupus nephritis is associated with APOL1</article-title>. <source>Arthritis Rheumatol</source>. <year>2014</year>;<volume>66</volume>: <fpage>390</fpage>–<lpage>396</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1002/art.38220" xlink:type="simple">10.1002/art.38220</ext-link></comment> <object-id pub-id-type="pmid">24504811</object-id></mixed-citation></ref>
<ref id="pntd.0004903.ref092"><label>92</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Larsen</surname> <given-names>CP</given-names></name>, <name name-style="western"><surname>Beggs</surname> <given-names>ML</given-names></name>, <name name-style="western"><surname>Saeed</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Walker</surname> <given-names>PD</given-names></name>. <article-title>Apolipoprotein L1 risk variants associate with systemic lupus erythematosus-associated collapsing glomerulopathy</article-title>. <source>J Am Soc Nephrol</source>. American Society of Nephrology; <year>2013</year>;<volume>24</volume>: <fpage>722</fpage>–<lpage>725</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1681/ASN.2012121180" xlink:type="simple">10.1681/ASN.2012121180</ext-link></comment> <object-id pub-id-type="pmid">23520206</object-id></mixed-citation></ref>
<ref id="pntd.0004903.ref093"><label>93</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Baral</surname> <given-names>TN</given-names></name>, <name name-style="western"><surname>Magez</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Stijlemans</surname> <given-names>B</given-names></name>, <name name-style="western"><surname>Conrath</surname> <given-names>K</given-names></name>, <name name-style="western"><surname>Vanhollebeke</surname> <given-names>B</given-names></name>, <name name-style="western"><surname>Pays</surname> <given-names>E</given-names></name>, <etal>et al</etal>. <article-title>Experimental therapy of African trypanosomiasis with a nanobody-conjugated human trypanolytic factor</article-title>. <source>Nat Med</source>. <year>2006</year>;<volume>12</volume>: <fpage>580</fpage>–<lpage>584</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1038/nm1395" xlink:type="simple">10.1038/nm1395</ext-link></comment> <object-id pub-id-type="pmid">16604085</object-id></mixed-citation></ref>
<ref id="pntd.0004903.ref094"><label>94</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Simarro</surname> <given-names>PP</given-names></name>, <name name-style="western"><surname>Cecchi</surname> <given-names>G</given-names></name>, <name name-style="western"><surname>Franco</surname> <given-names>JR</given-names></name>, <name name-style="western"><surname>Paone</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Diarra</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Ruiz Postigo</surname> <given-names>JA</given-names></name>, <etal>et al</etal>. <article-title>Mapping the capacities of fixed health facilities to cover people at risk of gambiense human African trypanosomiasis</article-title>. <source>Int J Health Geogr</source>. BioMed Central; <year>2014</year>;<volume>13</volume>: <fpage>4</fpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1186/1476-072X-13-4" xlink:type="simple">10.1186/1476-072X-13-4</ext-link></comment> <object-id pub-id-type="pmid">24517513</object-id></mixed-citation></ref>
<ref id="pntd.0004903.ref095"><label>95</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Zinner</surname> <given-names>D</given-names></name>, <name name-style="western"><surname>Wertheimer</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Liedigk</surname> <given-names>R</given-names></name>, <name name-style="western"><surname>Groeneveld</surname> <given-names>LF</given-names></name>, <name name-style="western"><surname>Roos</surname> <given-names>C</given-names></name>. <article-title>Baboon phylogeny as inferred from complete mitochondrial genomes</article-title>. <source>Am J Phys Anthropol</source>. Wiley Subscription Services, Inc., A Wiley Company; <year>2013</year>;<volume>150</volume>: <fpage>133</fpage>–<lpage>140</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1002/ajpa.22185" xlink:type="simple">10.1002/ajpa.22185</ext-link></comment> <object-id pub-id-type="pmid">23180628</object-id></mixed-citation></ref>
</ref-list>
</back>
</article>